MBA Program inHealth Care Management

2012RESUMEBOOK

Wharton

ContentsProgram Description. . . . . . . . . . . . . . . . . . . . . . . 4

Curriculum. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5

Graduates. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6-29

Administration . . . . . . . . . . . . . . . . . . . . . . . . . . 30

Health Care Program Mentors . . . . . . . . . . . 31-36

Internship Sponsors . . . . . . . . . . . . . . . . . . . . . . 37

Faculty . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38-39

Thank you for your interest in the Wharton MBA Programin Health Care Management. For further information, resumes, and appointments, contact:

June Kinney, Associate Director, MBA Program in Health Care ManagementThe Wharton SchoolUniversity of Pennsylvania3641 Locust WalkPhiladelphia, PA 19104-6218

215.898.6861 | Fax 215.573.2157 email: aleszczc@wharton.upenn.edu

For information on the Wharton Health Care Management Alumni Association visit www.whartonhealthcare.org

For detailed information on the Health Care Management Department educational programs visit http://hcmg.wharton.upenn.edu/

3

MBA GraduatesThe University of Pennsylvania was founded byBenjamin Franklin in 1740. Although the Universitycarries the name of the Commonwealth, it is not a state university but an independent, private,nonsectarian institution. As one of the country’searliest educational institutions, it has consistentlyinitiated advances in teaching and research andhas steadily generated specialized fields of highereducation. Penn, as the University is commonlyknown, was the first American university to formdepartments of botany, hygiene and public health,surgical research, and research medicine. The University School of Medicine, formed in 1765, was the first in North America, as was the teachinghospital founded in 1874. The world’s first psychological clinic was opened at Penn in 1896.

The Wharton School, in the same spirit of innovation and excellence, was the world’s first collegiate school of business and management.Founded in 1881 with a gift from Joseph Wharton,the Philadelphia industrialist and philanthropist,the Wharton School undertook the pioneer stepsin elevating training for business significantlyabove its previous level as noncollegiate commer-cial education. In 1921, the formation of the Graduate Program signaled the advancement ofbusiness administration at Wharton to the highestlevels of professional education.

Today, the Wharton School has more than 270 faculty members teaching in both the graduateand undergraduate divisions and conducting a continually expanding volume of research. The1600 students in the master’s degree program may choose from among more than 200 coursesand over 18 majors and concentrations, a varietyreflecting the fact that the Wharton educationcomplements the career goals of the individual.

This brochure is provided to introduce you to the 2012 Wharton Health Care Management Program graduates.

We encourage you to consider these individuals for employment.

2012Health Care Management

4

The Graduate Program in Health Care Management is a full-time two-year MBA curriculum offered by the Health Care Manage-ment Department of the Wharton School. Theprogram, the principal educational effort at theLeonard Davis Institute of Health Economics, is designed to provide managerial and technical expertise to students interested in the health care management field. By combining the skills of the Wharton disciplines with sensitivity to theneeds of health care providers and recipients, the Wharton MBA health care graduate can effectivelymanage the delivery of health services and products at all levels.

The Program has produced graduates who havechosen careers in hospitals and other medical institutions, pharmaceutical, biotechnology andmedical device companies, financial services, entrepreneurial ventures, consulting firms, insurance firms, private health industry, and federal, state, and local government. Many of these MBA graduates now hold positions as chief executive officers, directors, and other keydecision makers in health care organizations.

The Leonard Davis Institute of Health Economics(LDI) is an interdisciplinary center for research and education in the organization, financing, and delivery of health care. Through LDI, Universityof Pennsylvania faculty and staff work togetheron issues concerning health policy, health insurance, managed care, hospitals, corporations,pharmaceutical companies, and other health-related organizations. Established in 1967, the Institute appropriately bears the name of the lateLeonard Davis, one of the foremost innovators in private health insurance in the United States. Hewas the founder of Colonial Penn Group, Inc., acompany that has pioneered in insurance for olderAmericans. Both Mr. Davis and Mrs. Sophie Daviswere generous benefactors to the University ofPennsylvania, contributing basic support for the activities of the Leonard Davis Institute.

Program Description

5

CurriculumThe Wharton Management Core

All students are required to complete the Wharton Management Core. The WhartonSchool’s core curriculum is designed to increasecrossfunctional integration, extend global experience, strengthen leadership training, and introduce new courses on key managementissues. The core curriculum provides groundworkin basic management disciplines: economics, finance, financial and cost accounting, management science, managing people and organizational design, marketing, operationsmanagement, the governmental and legal environment of business, statistics, and strategy.

• Ethics and Responsibility• Financial Accounting• Managerial Accounting• Statistical Analysis for Management• Decision Models and Uncertainty• Managerial Economics• Marketing Management: Program Design • Marketing Management: Strategy • Operations Management: Quality and Productivity

• Operations Management: Supply Chain Management

• Management of People at Work• Macroeconomics and the Global Economic Environment

• Corporate Finance• Competitive Strategy• Global Strategic Management• Government and Legal Environment of Business

• Management Communication• Foundations of Teamwork and Leadership

Global Immersion Program The Wharton Global Immersion Program is anoptional half-credit elective course that providesfirst-year students with an in-depth exposure tointernational business practices and first-hand insights into a foreign culture.

The Health Care Major Courses and Electives These courses promote an understanding of concepts, institutions, and issues involved in theorganization, financing, and delivery of healthservices and products in the United States.Health care electives are selected consistent with individual career objectives and interests.

Required• Health Services System• Health Care Field Application Project

Electives• Comparative Health Care Systems• Financial Management of Health Care Organizations

• Managed Care, Market Structure, and Health Care Delivery

• Health Care Marketing• Health Economics and Policy• Legal Aspects of Health Care• Management and Economics of Pharmaceutical and Biotechnology Industry

• Medical Devices• Management of Health Care for the Elderly• E-Health: Business Models and Impact• Management of Health Care Services Businesses

• Health Care Entrepreneurship• Private Sector Role in Global Health• Health Care Services Delivery:A Managerial Economic Approach

• Advanced Study Project

The Health Care Summer Internship The internship is a three-month management experience which provides the health care major an opportunity to work with a senior executive in an organization of particular interest to the student.

MBA ElectivesOpportunities are available for the health caremajor to pursue a second concentration in fieldssuch as entrepreneurship, marketing, finance, oroperations, or to pursue specialized knowledgein areas such as health care financing or withinspecialized segments of the health care industryincluding managed care organizations, hospitals,pharmaceutical and biotechnology companies,medical device companies, specialty services organizations, and long term care organizations.Graduate courses are available throughout the University.

Sebastian Aguilarsebastian.aguilar.wg12@wharton.upenn.eduNational Autonomous University of Mexico,Mexico City, MexicoB.I.E., Industrial Engineering, 2008

An opportunity in healthcare strategy consulting.

A.T. Kearney, Mexico CitySummer Consultant, Summer 2011Developed a Point of Sale strategy in Latin America for a top 10 pharma-ceutical company. Conducted industryresearch, market characterization and expert interviews. Managed work stream related to the financialassessment of the opportunity and evaluation of the Point of Sale strategy.

Pfizer, Mexico City, MexicoKey Accounts Coordinator, 2009-2010Conducted in-depth assessment of institutional market (30% of total subsidiary revenue); developed strate-gies to increase market penetrationthrough improved targeting and customer service. Conducted portfolioanalysis of 20 products and 35 institu-tional clients to optimize promotionalinvestment. Led 6-person teamcharged with developing Pfizer Mexico’s 2010-2011 Customer Service Plan.

Pfizer, Mexico City, MexicoTerritory Management Analyst, 2007-2009Developed and executed a resource allocation project to determine optimal size and structure of salesforce. Increased national market shareby 3% through territory realignment,and by 11% among new reps by de-signing new training materials.

Nicholas S. Andersonnicholas.anderson.wg12@wharton.upenn.eduMacalester College, St. Paul, MNB.A., Economics and Spanish, 2004CFA Charterholder, 2008

An opportunity to combine my payorand business development experiencewithin an entrepreneurial healthcareservices team.

Medco Health Solutions, Franklin Lakes, NJSummer Associate, Summer 2011Performed due diligence and construc -ted detailed financial projection modelto acquire oncology pharmacy with$96M revenue. Communicated primaryareas of risk and valuation sensitivityto diligence team. Developed marketresearch and presentation to pitch senior executives on strategy to sellservices through untapped hospitalchannel.

Blue Cross Blue Shield of Minnesota,Eagan, MNSenior Financial Analyst, 2006-2010Financial Analyst, 2005-2006Analyzed acquisition, divestiture andjoint venture opportunities. Executed4 transactions ranging up to $170M inenterprise value. Collaborated withCEO of $10M revenue subsidiary to orchestrate aggressive financial turnaround that improved EBITDA by$8M. Led a cross functional team todevelop strategic proposal to manageMedicare business of 6 other healthplans, securing $50M incremental annual revenue.

Jeffrey Slocum & Associates, Minneapolis, MNInvestment Analyst, 2004-2005Designed and implemented propri-etary models to analyze investmentmanagers and institutional client port-folios. Coordinated asset transfers andquarterly performance reporting for 4 clients.

Anne Marie Aponteanne.aponte.wg12@wharton.upenn.eduCornell University, Ithaca, NYB.S., Industrial & Labor Relations, 2006

An opportunity within an innovativehealthcare organization working tolower costs and improve the quality of healthcare delivery.

Accolade, Plymouth Meeting, PASummer Associate, Product Development,Summer 2010Served as project manager for the development and implementation of new products designed to enhancethe interaction between clients and their healthcare providers and facilitate better health outcomes.

Bristol-Myers Squibb, Princeton, NJAssociate Territory Business Manager, 2009-2010Human Resources Generalist, 2008-2009Human Resources Associate, 2006-2008Promoted the portfolio of cardiovascu-lar and metabolic products to a customer base of primary care practi-tioners. Served as the HR lead for theManaged Markets Sales organizationalrestructuring, resulting in greater spe-cialization among account executivesand improved alignment with thecompany’s product portfolio. Served as project manager of the U.S. Pharma-ceutical culture team and authored adecision role clarity model, which hasbeen adopted companywide to in-crease accountability and speed thedecision-making process. Designed and implemented an attrition modelyielding $25M in cost savings during2008. Developed and maintained relevant metrics to ensure adherenceto attrition model assumptions andcommitments.

6

Anthony Baldaanthony.balda.wg12@wharton.upenn.eduCornell University, Ithaca NYB.S., Magna Cum Laude, Applied Economics and Management with Marketing Concentration, 2004

A leadership opportunity in an entrepreneurial healthcare organization.

Medtronic CardioVascular, Minneapolis, MNMBA Summer Associate – CoreValve Downstream Marketing, Summer 2011Led team to develop internationallaunch plan for new CoreValve Tran-scatheter Aortic Valve implant. Helpedmanagement develop a new brandstrategy focused on CoreValve portfo-lio while leveraging Medtronic’s brandequity. Analyzed internal structuresand recommended CRM software solution to manage key opinion leaders across multiple business units and countries.

Medicomp, Inc., Melbourne, FLVice President, Marketing and Strategic Development, 2008-2010Led initiatives for large partnershipcontracts, joint ventures and clinicaltrials. Negotiated exclusive contracts,including the largest Atrial Fibrillationclinical trial involving 3000 patientsacross 125 global centers. Researchedand developed detailed plans for multiple new products includingiPhone cardiac applications. Spear-headed commercialization of innova-tive new wireless cardiac telemetrydevice integrated with cellular technology.

Medicomp, Inc., Melbourne, FLDirector of Marketing, 2004-2008Management responsibility for marketing, PR, advertising, customerservice and manufacturing. Achieved20% year-on-year annual revenuegrowth. Executed 3 successful diagnostic ECG product launches. Developed innovative new marketingcampaigns to combat decreasing insurance reimbursement.

Jamil M. Begjamil.beg.wg12@wharton.upenn.eduUniversity of Pennsylvania, Philadelphia, PAMasters in Biotechnology, 2005B.S.E., Bioengineering, 2004

An opportunity to apply my businessand scientific expertise to challenging issues in the biopharma industry togrow a business while addressing serious unmet clinical needs.

Genentech, South San Francisco, CABusiness Development Intern, Summer 2011Managed the evaluation of ocular delivery technologies for marketedand development stage products. Ledan R&D team to develop a researchplan assessing the feasibility of an ocular delivery technology. Structured,negotiated, and closed a feasibility assessment agreement with an oculardelivery startup.

NuPathe Inc., Conshohocken, PABusiness Development and Commercial Operations Manager, 2009-2010 (60% of time)Created a launch plan for the company’s lead product and built dynamic financial model for strategicplanning, business development, andIPO underwriting.

TetraLogic Pharmaceuticals, Inc.,Malvern, PABusiness Development Manager, 2009-2010 (40% of time)Created an R&D plan for a novel drugfrom discovery through clinical proofof concept including preclinical andclinical trial planning, financial fore-casting, and commercial opportunityassessment.

Quaker BioVentures, LLC, Philadelphia, PA Analyst, 2007-2009Contributed to 4 new and 8 follow-oninvestments representing ~$470M ofsyndicate capital. Managed diligence,negotiations, and deal execution forseed to late stage investments acrossthe life science industry.

Deepshikha Charandeepshikha.charan.wg12@wharton.upenn.eduUniversity of Pennsylvania, Philadelphia, PAB.A., Summa Cum Laude, Biology, 2007Perelman School of Medicine at the Universityof PennsylvaniaM.D. Candidate, 2012

To use my business and medical knowledge to improve delivery of care to underserved populations bothdomestically and abroad.

McKinsey & Company, Chicago, ILSummer Associate, Summer 2011Worked with an academic medical center to understand the effects ofhealthcare reform on hospitals. Specifically, analyzed the consequencesof Medicare wage reformulations,healthcare exchanges, and account-able care organizations on health systems. Created a long-term strategicplan to ensure financial and clinicalsuccess for the health system.

University of Pennsylvania, Philadelphia, PAResearch Assistant, 2011-presentAnalyzed the discharge planningprocess and studied the effect of novelpatient education tools in reducingthe rate of hospital readmissions. Patient literacy has been shown tohave an effect on compliance with discharge instructions, which providesa lever to reduce readmissions in an environment where Medicare reimbursement for hospital readmissions will decrease.

Homeless Health Initiative, Philadelphia, PAStudent Co-Chair, 2007-2009Coordinated visits to a free pediatricclinic for homeless children. Implemen -ted peer mentorship model to increasethe number of children seen duringeach visit.

7

Jigar Chokseyjigar.choksey.wg12@wharton.upenn.eduNorthwestern University, Evanston, ILB.S., Magna Cum Laude, Biomedical Engineering and Economics, 2007

An opportunity to analyze, invest in and improve healthcare companies.

Bank of America Merrill Lynch, San Francisco, CASummer Associate, Investment Banking,Summer 2011Focused on healthcare coverage onthe West coast, primarily including biopharmaceutical and medical devicescompanies. Advised financial sponsorsand strategic companies on the poten-tial buyout and acquisition, ~$600M,of a medical devices. Provided a bio-pharma with asset acquisition recom-mendations based on a comprehensiveoverview of interested marketed andpipeline clinical assets in prostate cancer.

Booz & Company, Chicago, ILSenior Consultant, 2009-2010Consultant, 2007-2009Collaborated with clients to completecases in strategic planning, portfoliomanagement, due diligences and capability building. Engagements primarily focused in healthcare acrossthe entire value chain: payor, provider,biopharma and other services such asPBM and Health IT. Advised acquisitiontargets for life, disability and dentalinsurance company. Conducted duediligence for acquisition targets to expand client’s business from $200Mto $500M in annual premiums. Pro-vided a U.S. and international growthstrategy for hospital software vendor.Wrote a pharmaceutical and biotech-nology R&D industry effectivenessstudy; study published in “In Vivo”magazine.

R. Carter Clementrutledge.clement.wg12@wharton.upenn.eduPrinceton University, Princeton, NJB.S.E., Structural Engineering & Architecture, 2004Perelman School of Medicine at the Universityof Pennsylvania, Philadelphia, PAM.D. Candidate, 2012

Daniel Cuevas Rimochdaniel.cuevas.rimoch.wg12@wharton.upenn.eduUniversidad Iberoamericana, Mexico CityBachelor in Industrial Engineering, 2008

An opportunity in healthcare real estatewhere I can leverage my experience inreal estate banking with my expertise in the pharmaceutical industry.

A.T. Kearney, Mexico CitySummer Associate, 2011Assessed Chief Purchasing Officer onoptimal sourcing strategy for 30 keyinputs purchased by bottling company,with analysis projecting over $60Min annual savings. Investigated differ-ences in purchasing practices across 9countries for transnational client, rec-ommending sole purchasing processwhich would avoid over $8M in expenditure control.

Evercore Partners, Mexico CitySenior Analyst, 2009-2010Created financial models using netasset value, discounted cash flow andcomparable public companies whichwere key to propose merger opportu-nities to developers in residential, retail, office, industrial and hotel segments. Developed master plan for $120M tourism-residential projectin Baja California. Prepared presenta-tion to target new institutional in-vestors and determined optimalurbanization and edification rate thatmatched industry’s market demand.

Laboratorios Liomont, Mexico CityProject Manager, 2007-2008Selected by senior management to lead troubled overhaul project. Re-organized project’s Gantt chart toreduce production line stoppage fromthree to two months and developedcontingency plan to produce+1,000,000 units of out-of-stock product during stoppage. Additionally,coordinated Quality Control and Oper-ations Departments in implementationof FDA required technology.

8

An opportunity to combine my clinicaland business experiences to developand implement novel approaches for the delivery of healthcare.

Children’s Hospital of Philadelphia,Philadelphia, PA Operations Consultant, 2010-2011 Participated in a series of three internal-improvement initiatives whilein medical and business school. Workwas aimed at improving operationalefficiency and financial impact of cur-rent systems for patient discharge, sur-gical case planning, and operatingroom setup. Involvement includedleadership positions and extensiveproject management experience.

Penn Biotech Group, Philadelphia, PA Intern/Consultant, 2008-2010Served as project manager for a teamof 7 University of Pennsylvania gradu-ate students on a consulting projectfor a major medical device companythat involved identifying physicianpreferences and redesigning clinicalsupplies. Awarded prize for outstand-ing project of the semester. Worked ona second team for a major health in-surance firm to develop a business casefor a new product.

BroadReach Healthcare, Cape Town, ZA Operations Consultant, 2006-2007Awarded Princeton-in-Africa fellow-ship to spend a year with this health-care consulting firm’s non-profitbranch in South Africa. Worked on a capacity building engagement aimed at expanding HIV treatment at 9 SouthAfrican public hospitals. Over thecourse of the year, moved into a proj-ect manager role to streamlineprocesses and improve operational efficiency.

Cody N. Dashiell-Earpcody.dashiell-earp.wg12@wharton.upenn.eduYale University, New Haven, CT B.A., Magna Cum Laude, Anthropology, 2006Perelman School of Medicine at the Universityof Pennsylvania, Philadelphia, PAM.D. Candidate, 2012

An opportunity to improve primary caredelivery using my clinical and businesstraining.

HopeLab, Redwood City, CAMarketing and Research Intern, Summer 2011Performed comprehensive marketingdata analysis for Re-Mission, avideogame for children with cancer.Created communications plan for targeting healthcare providers. Formulated strategy for future prod-uct development in the pediatric oncology space.

PolicyLab, Children’s Hospital of Philadelphia, Philadelphia, PAGraduate Policy Fellow, 2010-2011Conducted a national survey of sustainable evidence-based mentalhealthcare programs for children forthe Mental Health Department of theCity of Philadelphia.

Siempre Unidos, San Pedro Sula, HondurasResources and Development Director 2006-2007Facilitated communication betweenthe senior management at three HIVclinics in Honduras and the U.S.-baseddevelopment team. Oversaw expansion of the only HIV treatmentcenter on the island of Roatan, and redesigned website to increasefundraising capabilities and enhanceorganizational brand.

Peter B. Dermanpeter.derman.wg12@wharton.upenn.eduStanford University, Stanford, CAB.S., Honors, Biology, 2007Perelman School of Medicine at the Universityof Pennsylvania, Philadelphia, PAM.D. Candidate, 2012

An opportunity to use my medical and business expertise to develop innovative clinical environments andmedical technologies.

Hospital of the University of Pennsylvania, Department of Orthopaedic Surgery, Philadelphia, PAResearch Associate, 2010-presentAuthored over 10 scholarly articles on topics including medical devices,medical education and health econom-ics. Awarded Leonard Davis Institute’sHealth Policy Research Prize for economic analysis of reductions in physician reimbursement on system-wide healthcare expenditures.

McKinsey & Company, Dallas, TXSummer Associate, Summer 2011Implemented a nationwide sales force reorganization for a major pharmaceutical wholesaler with projected savings exceeding $14M annually. Segmented accounts, re-designed territories, drafted job descriptions, performed financialanalysis and coordinated across interrelated work streams to manageorganizational change.

Ben Franklin Technology Partners,Philadelphia, PAIntern, Life Sciences Investment Group, Summer 2008Conducted due diligence on prospec-tive investments of up to $500,000.Evaluated scientific feasibility andcompetitive, regulatory and patent environment. Supervised portfoliocompanies by interacting directly with management and overseeingcompany board meetings.

Kyle P. Dowkyle.dow.wg12@wharton.upenn.eduRensselaer Polytechnic Institute, Troy, NYB.S., Summa Cum Laude, Biomedical Engineering, 2007

An opportunity to apply my interests inbusiness and medical technology to thelife science/medical device industry.

5AM Ventures, Waltham, MASummer Intern, Summer 2011-PresentAssisted biotech portfolio company,Fourteen22, with corporate strategyand business development. Evaluatedemerging market (EM) healthcare sys-tems and sales potential to rank orderEM opportunities for biologics. Devel-oped valuation models of emergingand developed markets to advise onthe terms of Fourteen22’s strategicpartnership negotiations. Identified$2M-$20M of additional earnings on a manufacturing deal leading to dealrestructuring. Measured market and financial impact of various clinical go-to-market strategies.

Siemens Healthcare Diagnostics, Norwood, MASystems Engineer II, 2009-2010Systems Engineer I, 2007-2009Led the development of prototypesoftware used for diagnostic instru-ment operation. Managed teams fortechnological expansion. Created software programs for operating sophisticated engineering prototypesand became resident expert in motioncontrol. Led multidisciplinary teams onproduct troubleshooting and problemsolving. Developed programs to increase employee time efficiency with experimental and data analysis.

9

Brandon D. Einsteinbrandon.einstein.wg12@wharton.upenn.eduYale University, New Haven, CTB.A., Molecular, Cellular, and DevelopmentalBiology: Neurobiology Track, 2007Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PAM.D. Candidate, 2012

An opportunity to integrate my clinical and business expertise to provide strategic leadership in thehealthcare industry.

Goldman Sachs & Co., New York, NYSummer Associate, Healthcare Group, Summer 2011Performed valuation and M&A analysisand prepared company-specific presentations detailing strategic acquisitions, initial public offeringsand high-yield debt financings forbiotechnology, specialty pharmaceuti-cal and healthcare service companies.

Sheridan Healthcare, Inc., Sunrise, FLSummer Associate, Summer 2008Performed pro forma analysis of newlysourced radiology practices to estimatefuture margins, volume and payer mix. Analyzed return potential forphysician practice. acquisitions.

RootSuit, LLC, Philadelphia, PACo-Founder, 2007-2011Launched online retail company. Employed detailed metrics to directadvertising to grow revenues to$200,000 annually.

Medical Student Web, LLC, Philadelphia, PACo-Founder, 2007-2008Established royalty-based company togrant access to high quality medicalschool application materials. Licensedcontent from students and wrote contract for royalty provisions.

Students for Organ Donation, New Haven, CTNational President, 2003-2007Created international network fororgan donation awareness; registered10,000+ new donors; recruited andmanaged 110 university chapters.

Brenton B. Fargnolibrenton.fargnoli.wg12@wharton.upenn.eduUniversity of Pennsylvania, Philadelphia, PAB.A., Summa Cum Laude, Benjamin Franklin Scholar, University Scholar, Biological Basis of Behavior, 2007Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PAM.D. Candidate, 2012

An opportunity to use my medical andbusiness expertise to develop healthcareinnovations.

J.P. Morgan, New York, NYSummer Associate, Healthcare InvestmentBanking, Summer 2011Worked across healthcare verticals including biotech, pharma, medical devices, and healthcare services. Developed buy-side transaction experience, reviewed strategic alternatives for defense against activisthedge funds, performed valuationanalyses, presented potential M&A opportunities to clients’ executiveteams.

Blue Cross & Blue Shield of Rhode Island,Providence, RISummer Intern, Health Management and Integration, Summer 2008Led team in designing Medical HomePilot, which was expanded statewide,to incentivize patient outcomes and the use of health IT, physician extenders, and generic drugs. Concep-tualized and built predictive model for diabetes disease management and presented model nationally.

Penn Center for Molecular Studies in Digestive and Liver Diseases, Philadelphia, PANIH Student Scholar, 2005-2007Performed basic science research on cancer signaling pathways by formulating hypotheses, designingand conducting laboratory experi-ments, and analyzing data. Publishedcancer research findings in peer-reviewed journal and presented findings at national conferences.

Sarah S. Fennellsarah.fennell.wg12@wharton.upenn.eduDuke University, Durham, NCB.A., Cum Laude, Psychology, 2007

10

An opportunity to use my business experience to improve healthcare services and delivery.

The University of Virginia Medical Center, Charlottesville, VAAdministrative Resident and CEO Intern,Summer 2011Led financial and strategic analysis of current capacity constraints and potential patient volumes in order toassess feasibility of new dialysis clinicin neighboring community. ExecutedBusiness Plan and Pro Forma to beused in construction and operation ofdialysis clinic. Developed “DepartmentSharing Program” designed to encour-age clinical departments to improve financial and quality performance in accordance with new Value BasedPurchasing Health Care Reform rule.

The Advisory Board Company, Washington, DCAssociate Director of Business Development,2007-2010Developed strategic relationships withsenior health executives at hospitalsand health systems in over 20 states to identify the membership portfoliothat best addressed organizational priorities leading to new investmentsin Advisory Board programs. Led clinical team in sales and reached160% of goal in first half of 2009.Launched membership for post-acutecare organizations, expanding businessinto new market in anticipation ofreadmission reduction initiatives included in Health Care Reform Bill. Innovated sales model to foster clienttrust and lower cycle time by focusingon preparation. Presented strategiesfor restructured model to leadershipteam, fellow Directors, and new hireson a quarterly basis.

Aaron N. Flinkaaron.flink.wg12@wharton.upenn.eduWilliams College, Williamstown, MAB.A., Economics and Psychology, 2003

An opportunity in strategy or businessdevelopment focused on the healthservices industry.

McKesson, San Francisco, CA Intern, Corporate Strategy and Business Development, Summer 2011Conducted primary and secondary research to identify opportunities forshort- and long-term growth withinprimary care. Presented recommenda-tions to senior executive team, outlining a roadmap to capture long-term opportunities without sacrificingshort-term opportunities.

The Advisory Board Company, Washington, DCDirector, 2008-2010Associate Director, 2005-2008Associate, 2005Developed strategic relationships withsenior executives at over 40 hospitalsand health systems, including Yale-New Haven, University of Chicago Medical Center, NorthwesternMemorial, Brigham and Women’s andAdvocate Healthcare. Leveraged thoserelationships to identify areas of needfor health systems, proposed AdvisoryBoard solutions and negotiated over$4M in new firm revenue. Additionally,launched new revenue cycle technol-ogy initiative, integrating new tech-nology acquisition with enhancedconsulting services, establishing newpresence for the Advisory Board in thepatient access terrain. Across tenure,recruited, trained and managed eightAssociates, taking responsibility fortheir career development, with sevenof eight receiving promotions withinfirst year of Advisory Board tenure.

David N. Flynndavid.flynn.wg12@wharton.upenn.eduUniversity of Wisconsin, Madison, WIB.S., With Honors, Phi Beta Kappa, Molecular Biology, 2005Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PAM.D. Candidate, 2012

An opportunity to use my clinical, business, and research training to improve healthcare quality and delivery.

Accolade Inc., Plymouth Meeting, PASummer Associate, Summer 2011Worked closely with CMO and ChiefActuary to analyze insurance claims information and calculate low backpain-related healthcare expenses forlarge employee population. Auditedrecordings of telephone calls betweenclients and Accolade Clinical Health Assistants, identifying best practicesand opportunities for improvement.Presented results and recommenda-tions to executive team.

Mayo Clinic, Rochester, MNSystematic Review Coordinator, 2006-2007Coordinated international study ofclinical trial methodology involving50+ expert clinicians and more than1,000 published clinical trials. Oversawall stages of study process for system-atic reviews and meta-analyses of clinical topics in multiple disciplines.Results published in high-impact medical journals, including JAMA and Mayo Clinic Proceedings.

Pasteur Institute, Paris, FranceFulbright Fellow, 2005-2006Conducted molecular virology experi-ments identifying novel interactionsbetween human host cell proteins and pathogenic proteins from multipleviruses. Assisted with experiment design, data acquisition and analysis,and manuscript preparation. Resultspublished in PloS Pathogens.

Adrian M. Galeadrian.gale.wg12@wharton.upenn.eduVanderbilt University, Nashville, TNB.E., Honors, Mechanical Engineering and Mathematics, 2004 Stanford University, Palo Alto, CAM.S., Mechanical Engineering, 2006

An opportunity to grow and manage anentrepreneurial medical device company.

Abbott Labs, Santa Ana, CAStrategic Marketing Intern, Medical Optics Division, Summer 2011Created global launch plan for best-in-class e-commerce platform. Per-suaded management of budgetingand strategy to maximize competitiveadvantage and increase adoption. Alsodeveloped strategy for introduction of a mid-tier intraocular lens. Recom-mended European launch predicted to generate additional NPV of $25M.

Medtronic Inc., Santa Rosa, CAMarket Development Analyst, Vascular Division, 2008-2010Developed global market models, segmentations, and country prioritiza-tions for marketing team and corpo-rate strategic plans. Created andlaunched novel field marketing toolfor 125 person sales forces in U.S. andEurope that identified high potentialregions; tool nominated for Medtronic “Marketing Excellence Award.”

R&D Engineer2006-2008Managed teams of engineers as Technical Lead for two stent graftproduct development projects. LedFDA interactive technical reviews and received Medtronic “Star of Excellence” award for exceptional involvement with 60-day PMA approvals.

11

Evan Gibsonevan.gibson.wg12@wharton.upenn.eduYale University, New Haven, CTB.A., Economics, 2004University of Pennsylvania, School of Engineer-ing and Applied Sciences, Philadelphia, PAM.B. Candidate, Biotechnology, 2012

A strategic marketing or business development opportunity at a biophar-maceutical or diagnostic company.

Abbott Laboratories, Abbott Park, ILMBA Intern, Immunology, Summer 2011Collaborated with Senior Managers of a specialized sales force to developstrategies and tactics for hospital accounts. Assessed recent develop-ments in the Section 340B Drug PricingProgram and developed recommenda-tions for maintaining the long-termsuccess of the immunology franchise.Worked closely with sales representa-tives and consultants to create an account segmentation tool to standardize key tactics for differenttypes of hospitals.

JMP Securities, San Francisco, CASenior Associate, 2007-2010Analyst, 2004-2007Helped build the Life Sciences Invest-ment Banking Group while completing35 financings totaling $2B in gross proceeds and 3 M&A transactions representing over $260M in value.Managed cross-functional teams thatincluded C-level management, lawyers,accountants, and JMP personnel to execute financing transactions. Spear-headed clinical, regulatory, and finan-cial due diligence for numerous clientsand prospective clients. Developedstrategic and financing recommenda-tions and presented to client manage-ment teams and directors.

Kyle G. Gilbridekyle.gilbride.wg12@wharton.upenn.eduDartmouth College, Hanover, NHA.B., Magna Cum Laude, History, 2005

An opportunity to operate and invest in innovative healthcare companies.

Medtronic, Minneapolis, MNSummer Leadership Development MarketingAssociate, Summer 2011 Evaluated next-generation cardiac device data analytics portfolio to improve customers’ clinical and economic outcomes. Identified keyproduct attributes and developmentalconsiderations through customer interviews and competitive research.Assessed organizational capabilities tosuccessfully launch and monetize suiteof data solutions. Led cross-functionalteam in creating new data reportingtool for injectable cardiac monitoringdevice.

Ferrer Freeman & Company, Greenwich, CTAssociate, 2008-2010Analyzed private equity investmentopportunities for a $900M healthcare-focused fund. Provided strategic guidance to 3 portfolio companies as aBoard observer. Partnered with seniormanagement to execute portfoliocompanies’ strategic plans, improveoperations, and identify acquisitiontargets. Designed pricing model forpharmaceutical marketing provider,improving profit margins and businessdevelopment initiatives.

Thomas Weisel Partners, New York, NYAnalyst, 2005-2008Provided corporate finance and strategic advisory services to growth-stage healthcare companies. Managedmarketing of Obagi Medical Products’$145M common stock offering. Evaluated 15 acquisition targets forNoven Pharmaceuticals, resulting in$125M acquisition of JDS Pharmaceuti-cals. Created fairness opinion for FoxHollow Technologies’ $780Mmerger with ev3.

R. Scott Glassronald.glass.wg12@wharton.upenn.eduWake Forest University, Winston-Salem, NCB.S., Cum Laude, Analytical Finance, 2005

An opportunity to build successful businesses through healthcare focusedprivate equity investing.

Solstas Lab Partners, Greensboro, NCIntern, Welsh Carson Portfolio Company,Summer 2011Managed due diligence and developedintegration plans for four add-on acquisitions in the clinical lab sector.Facilitated lender communication anddiligence process for debt refinancingto support acquisitions.

Tailwind Capital Partners, New York, NYAssociate, 2008-2010Evaluated healthcare and businessservices investments for the firm’s$775M inaugural fund. Led top-downindustry analysis, formed investmentthesis, fostered new relationships withintermediaries and executives to identify new investment opportunities.Worked closely with portfolio compa-nies to manage capital requirementsand execute their strategic growthplans.

American Capital, Washington, DCAssociate, 2007-2008Reviewed buyout investment opportu-nities across the firm’s core focus sectors including outsourced businessservices, logistics and healthcare services. Developed investment thesisand managed diligence processes tofacilitate transaction closings.

Wachovia Securities, Charlotte, NCInvestment Banking Analyst, 2005-2007Worked across the healthcare, technol-ogy and business services industries to structure equity and mezzanine private placements for growth-stagecompanies. Developed core analyticaland financial skills and presentedanalyses to clients’ executive teams.

12

Gautam K. Guptagautam.gupta.wg12@wharton.upenn.eduUniversity of Chicago, Chicago, ILB.S., With Honors, Mathematics, 2005

An opportunity to grow successful software businesses as an active private equity investor and operator.

ION Capital Management, London, UKSummer Intern, Summer 2011Led due diligence and produced investment analyses on three London-based financial technology companies.Worked with management team todevelop pricing strategy for softwareproducts.

Vista Equity Partners, San Francisco, CA and Chicago, ILAssociate, 2008-2010Helped build a new office in Chicagoas its first associate. Evaluated over 40software companies around the world,both as new platform investments andas add-ons. Led teams of analysts andassociates to complete detailed quanti-tative and qualitative analyses on allpotential targets. Performed detailedfinancial, business, market, competi-tive and customer due diligencethrough calls with managementteams, industry experts, consultantsand customers to complete buy-sidetransactions. Managed a team of potential lenders, lawyers, and ac-countants while negotiating NDAs, financing terms, and SPAs on buy-sidetransactions and on sale processes. Implemented best practices at variousindividual portfolio companies andstandardized successful processes atcompanies across the portfolio.

Merrill Lynch, Palo Alto, CAM&A Analyst, 2006-2008

Dresdner Kleinwort Wasserstein, New York, NYInvestment Banking Analyst, 2005-2006

Daniel S. Haimovicdaniel.haimovic.wg12@wharton.upenn.eduHarvard College, Cambridge MAA.B., Biology, 2005

An opportunity to expand a growingbusiness into new markets in the U.S. or abroad.

Medtronic – Ventor Technologies, Netanya, IsraelSummer Associate, Summer 2011Created a business plan for Medtronicto develop an Israeli Innovation Center.

Alexandria Real Estate Equities, Inc.,New York, NYSenior Director Life Sciences & New Markets,January 2008-June 2010Led East Coast and European businessdevelopment strategy for specialtyREIT that develops R&D space for thelife science industry.

DiscoveryOrtho Partners, New York, NYAssociate, September 2006 – December 2007Launched DiscoveryOrtho with twopartners as spin-out of Hospital forSpecial Surgery Ventures to act as aninvestor and strategic consultant toearly-stage orthopedic, spine and consumer healthcare companies.

Hospital for Special Surgery, New York, NYResearch Assistant, Laboratory for Biomechanics and Biomaterials, Sept 2005-August 2006Evaluated and analyzed orthopedicimplants extracted from patients forproblems that led to removal.

David A. Hechtdavid.hecht.wg12@wharton.upenn.eduPrinceton University, Princeton, NJA.B., Politics, 2004

An opportunity to build successfulhealthcare businesses through a privateequity investing or corporate strategyrole.

EDG Partners, Washington, DCSummer Associate, Summer 2011Evaluated investment opportunities including the acquisition of a diabetesservices provider in bankruptcy, adurable medical equipment distribu-tor, and a pharmacoviligence company.Led commercial due diligence, devel-oped detailed business plans, createdoperating models and crafted invest-ment theses.

JER Partners, Washington, DCAssociate, 2008-2010Underwrote acquisitions and performed extensive due diligence on healthcare services businesses inthe post-acute care space includingskilled-nursing, hospice and rehabilita-tion therapy. Directed key business initiatives including restructuring$1.7B in debt, overseeing $100M capital expenditure program, refiningbusiness plans, leading follow-on acquisitions and managing saleprocesses.

Oliver Wyman, New York, NYConsultant, 2004-2007Top-tier consultant with strong projectmanagement and analytical thinkingskills. Selected projects include: launch-ing a Shariah-compliant bank in Doha,Qatar; building credit risk rating models for a major U.S. banking institution.

13

Maggie A. Hillmargaret.hill.wg12@wharton.upenn.eduOklahoma State University, Stillwater, OKB.S., Summa Cum Laude, Honors College Degree, Advertising and Marketing, 2005

An opportunity to leverage my opera-tional experience to provide strategicleadership in the healthcare industry.

Aegerion Pharmaceuticals, Boston, MAGlobal Marketing Consultant, Fall 2011-Spring 2012Corporate Strategy Intern, Summer 2011Conducted global commercial launchanalysis to identify necessary modifica-tions to launch timeline and cash flowforecast. Developed NDA and MAAmaterials to enable successful pre-submission interactions. Aligned long-term incentive program with 2-yearhiring plan. Assisted with 10-K prepa-ration and investor calls to facilitatesuccessful follow-on equity offering.

Alcon Laboratories, Tulsa, OKOphthalmic Sales Representative, 2008-2010Managed $3M in annual territory salesvolume. Grew market share throughKey Opinion Leader development, resulting in 48% increase in sales for a single product. Partnered with Marketing Department as member ofAdvisory Board to improve marketingmaterials. Named 2009 President’sClub winner for achieving top 10%sales goal attainment.

Merck & Co., Tulsa, OKProfessional Sales Representative, 2006-2008Evaluated and trained peers on bestpractice principles as Certified Repre-sentative Trainer. Leveraged managedcare advantages to educate physicianson potential co-pay savings, stimulat-ing increase in prescriptions for patients covered by targeted payers.

Elizabeth K. Jettonelizabeth.jetton.wg12@wharton.upenn.eduUniversity of Virginia, McIntire School of Commerce, Charlottesville, VAB.S. with Distinction, Beta Gamma Sigma, Commerce with Finance and Management concentrations, 2006

Manage business development and marketing for growth-equitybacked healthcare technology and services company.

Vivere Health, LLC, Franklin, TNMarketing Consultant, Summer 2011Managed business development, marketing, and public relations strategy for early-stage fertility surgery center and lab service provider.Efforts generated a 30% increase innew website visits over 3 months.

Ag Mednet, INC, Boston, MAVice President, Market Development, 2010Senior Director, Market Development, 2007-2009Led business development for health-care technology start-up providingelectronic transport of diagnostic images in clinical trials with clients including top 10 pharmaceutical companies. Spearheaded productlaunch to achieve 4 quarters of consecutive 100% revenue growth and implemented flat-line pricing model to double cash flow in year one of average deal. Developed marketingprograms, including the education of sales channel Contract Research Organizations accounting for ~40% of leads. Managed Project Managersto build robust training program anddrive user adoption with 5,000 users in more than 30 countries.

The Boston Consulting Group, Atlanta, GAAssociate Consultant, 2006-2007Generated earnings improvement plan for multi-national medical devicecompany and managed execution of $150M savings target across 16 initiatives.

Ian A. Josephian.joseph.wg12@wharton.upenn.eduTufts University, Somerville, MAB.S., Psychology, 2005

An opportunity to collaborate on strategic projects across healthcare sectors and functions.

McKinsey & Company, Florham Park, NJSummer Associate, Summer 2010Created a series of models, investiga-tions and interviews to optimize thesupply base of a healthcare servicescompany. Investigated potential vertical integration opportunities both domestically and abroad.

United BioSource Corporation, Boston,MA and London, UKSenior Research Associate, 2008-2010Designed health economic models thatformed the foundation of successfuldrug submissions to regulatory agen-cies in England, Norway and Canada;expanded coverage to more than 90Mnew patients. Managed research staffof 6 analysts and provided training in modeling techniques, includingMarkov and discrete event simulation,and regulatory submission strategy;promoted open, two-way feedback to encourage US/UK collaboration.

14

Brandon P. Katzbrandon.katz.wg12@wharton.upenn.eduUniversity of California San Diego, La Jolla, CAB.S., Honors with Distinction, Management Science, B.S., Bioengineering, 2006M.S., Bioengineering, 2007

A strategic leadership or business development opportunity in the healthcare industry.

McKinsey & Company, Palo Alto, CASummer Associate, Summer 2011Led client teams through strategic cost reduction analysis and executionfor a large hospital system. Imple-mented supply chain rationalizationprocesses and streamlined sourcing.

A&D Medical, San Jose, CAProduct Manager, 2008-2010Created and implemented multina-tional marketing strategy for a con-sumer and B2B medical electronicsmanufacturer. Developed new businessleads, executed marketing campaigns,and sourced innovative products tosupport company goals. Managed operational budgeting, product linesales targets, and margin control forbrands with $18M in annual sales and22% average growth.

Abbott Vascular, Santa Clara, CAAssociate Research Scientist, 2007-2008Designed and developed techniquesleading to patent applications for vascular therapy products andprocesses. Led preclinical research investigations in vascular cell therapyand biomaterials.

Elizabeth B. Kiernanelizabeth.kiernan.wg12@wharton.upenn.eduCornell University, Ithaca, NYB.A., History and Economics, 2005

An opportunity to work with an entrepreneurial team in the healthcareservices industry.

Castlight Health, San Francisco, CAProduct Marketing Associate, Summer 2011Designed and executed research project focused on identifying howconsumers make healthcare decisions.Incorporated external research andprimary customer research into actionable marketing and product recommendations. Proactively soughtout numerous additional products tosupport business development andsales teams.

Oliver Wyman, San Francisco, CA Associate, 2008-2010Consultant, 2005-2008Worked with a variety of clients acrossthe Health and Life Sciences industryto help grow businesses and imple-ment operational improvements. Executed projects, built senior clientlevel relationships and managed juniortalent. Led entrepreneurial practiceinitiatives focused on intellectual capital sharing, culture building, and external recruiting.

Michael L. Kijewskimichael.kijewski.wg12@wharton.upenn.eduWest Chester University of Pennsylvania, West Chester, PAB.S.Ed, Physics, 2004University of Pennsylvania, Philadelphia, PAM.M.P., Medical Physics, 2010

An opportunity to build new healthcaretechnology companies through entre-preneurship and venture investment.

Gamma Basics, Wayne, PAFounder, 2009-PresentDeveloped a novel medical radiationshielding design and analysis toolcalled grayCAD that helps hospitals assess their radiation safety compli-ance in radiation oncology, nuclearmedicine, and diagnostic imaging applications. Raised $120K angelround from the founders of BentleySystems. Sold first enterprise license toa major U.S.-based radiation oncology equipment manufacturer. Recipient of 2011 Wharton Venture award, 2010 Wharton Snider Seed award.

Veritas Medical Solutions, Malvern, PAPhysicist, Founding Team Member, 2008-2010Founding team member of Veritas, anoncologic radiation shielding manufac-turer and installer. Developed productR&D protocol, helping to create theworld’s most effective high-densityconcrete radiation shielding product.Developed rapid quotation physicsworkflow, allowing our six-memberteam to bid on over $70M of projectsin six months, securing over $10M of contracts in our first nine months.Designed radiation shielding for over fifty oncology facilities in tencountries.

Atomic International, Frederick, PAPhysicist, 2007-2008Developed computerized physics calculation system, allowing rapid scaling of quotation abilities. Providedphysics support to customers in sixcountries, significantly increasing customer retention. Completed rigorous product testing using LosAlamos National Laboratory’s LANSCEneutron beam.

15

Jin Suk Calvin Kimjin.kim.wg12@wharton.upenn.eduMassachusetts Institute of Technology, Cambridge, MAB.S., Materials Science Engineering, B.S., Economics, 2006Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PAM.D. Candidate, 2012

An opportunity to utilize my medicaland business backgrounds to improvehealthcare.

Boston Consulting Group, Boston, MAConsultant, Summer 2011 Worked with senior management at a large pharma company to formulatestrategies for academic and private alliances. Advised client on R&D strat-egy recommendations for partnershipswith over 10 universities, hospitals andresearch institutes.

International Clinical Epidemiology Network, New Delhi, IndiaAnalyst, Summer 2008Assisted in the validation of a simpli-fied India-adapted diagnostic tool forautism spectrum disorders in children,which is initially being utilized in over40,000 children and will be applied to other developing world countries.Designed a ~$10M budget for anIndia-wide study relating to childhoodmalnutrition for the WHO and USAID.

Goldman, Sachs & Co., New York, NYAnalyst, 2006-2007, Summer 2005, Summer 2004Created detailed pitch and executionbooks including M&A, Debt and EquityFinancing, LBO and, DCF, and mergerscenarios modeling for the followingselected transactions: IPO of LeMaitreVascular and athenahealth ($113M),Spin-off and formation of Hill-Rom/Hillenbrand, convertible debt for ViroPharma ($250M), debt for WellPoint ($1.5B) .

Stephen Y. Kimstephen.kim.wg12@wharton.upenn.eduUniversity of California, Los Angeles, CAB.A., Economics, 2004

An opportunity in impact investingwithin the healthcare industry.

Goldman Sachs & Co., New York, NYSummer Associate, Summer 2011Provided M&A advisory, anti-raid strategy, capital allocations analysis,debt-financing and other investmentbanking services to healthcare companies in the U.S. and China.

TechnoServe, Nairobi, KenyaVolunteer Consultant, Summer 2010Conducted a detailed value-chainanalysis. Negotiated with multi-national input providers on productofferings and work with governmentorganization on logistics issues inorder to help double the income offarmers across Kenya and Uganda.

Kaiser Foundation Health Plans,Pasadena, CAFinancial Project Manager, 2004, 2009-2010Provided inpatient DRG analysis revealing ~$90M in annual savings.Developed new detailed financial reforecast model that monitors $14B in expense activities. Led quarterly update presentations with Regional CFO.

L.E.K. Consulting, Los Angeles and San Francisco, CASenior Associate Consultant, 2005-2009Led teams of 4-5 through various research and analysis to validate investment thesis for PE firms. Advised senior management of majorhealth plan on Medicare strategies.Developed turn-around strategy forlarge PBM. Benchmarked operationalbest practices for large MCO. Devel-oped PMI strategy for large health-services company that acquired amajor regional player.

Yi-An Koyi-an.ko.wg12@wharton.upenn.edu Harvard College, Cambridge, MAA.B., Biology, 2007Harvard Kennedy School of Government, Cambridge, MAM.P.A. Candidate, 2013

An opportunity to apply my businessand policy expertise to provide strategicleadership in the healthcare industry.

Trinity Health, Novi, MIStrategic Planning Intern, Summer 2011Designed a survey and analyzed services offered across 40 hospitals in 9 states to develop a national strategyfor a geriatric service line. Developed abusiness plan to build an institute thataggregates and evaluates healthcareleadership and training programs.

amfAR, Washington, DCSpecial Assistant to Dr. Susan Blumenthal,former U.S. Assistant Surgeon General,2008-2010Managed projects related to HIV/AIDS,national health policy and reform, andother emerging health concerns. Ledteam of 28 to organize & execute aCapitol Hill Conference that included34 senior government leaders andhealth experts. Organized 4 Congres-sional Briefings and conducted policyresearch and analysis to develop 8 policy briefs. Co-authored 17 articles in The Washington Times, NewsweekOnline, and The Huffington Post.

Meridian International Center, Washington, DCProgram Manager, 2008-2010Developed strategy for building aglobal health program, launched initiative and contributed to fundingproposal that resulted in $95,000 forthe program.

16

Marcus J. Lanznarmarcus.lanznar.wg12@wharton.upenn.eduVanderbilt University, Nashville, TNB.S., Magna Cum Laude, Neuroscience, 2005

An opportunity to leverage my strategicconsulting and business developmentexperience.

Roche, Nutley, NJBusiness Development MBA Summer Associate, Summer 2011Conducted due diligence for one in-licensing opportunity and two acquisition opportunities, includingone potential white space acquisition. Performed analysis of market potentialand risks, evaluation of potential dealstructures, development of forecastmodels, identification of pricing strategies, discussions with key opinionleaders, projection of future develop-ment and marketing costs, and identification of potential synergieswithin Roche. Redesigned and optimized a valuation model used inthe evaluation of potential licensingdeals.

IMS Health Consulting, New York, NY Senior Consultant 2009-2010Consultant 2007-2009Analyst 2006-2007 Managed client relationships and directed junior staff to complete 10projects totaling over $4M in revenuefor top pharmaceutical companies. Facilitated business development activities in 2009 for over $4.1M inproject work; $2.5M in revenues sold.Led projects focused on developingpricing, reimbursement, commercial-ization and launch strategies as well as developing scenario-dependent revenue forecast models and emergingmarket strategies. Created IMSHealth’s New York community serviceprogram; led six service projects engaging over 250 volunteers.

Jennifer M. Leejennifer.lee.wg12@wharton.upenn.eduUniversity of California, Berkeley, CAB.A., Economics, 2005B.S., Business Administration, 2005

An opportunity to leverage my consulting and industry experience to provide strategic leadership at a healthcare services organization.

Becton Dickinson, Franklin Lakes, NJStrategic Marketing Intern, Summer 2011Analyzed opportunity for mobile technologies and smart drug deliveryproducts in acute care settings.

The TriZetto Group, Greenwood Village, COMBA Intern, Provider Strategy Group, Summer 2011Conducted initial analysis to identifypotential market entry opportunitiesin hospital revenue cycle management.

NewYork-Presbyterian Hospital, New York, NYManager, Patient Access ServicesManaged implementation of enter-prise-wide IT system for 20 clinics and3 campuses, successfully convertingfrom paper to electronic scheduling.Project resulted in a 25% increase inpatient volume and improved registra-tion quality. Spearheaded operationaldesign effort of new clinical building,including execution of new patient intake process, development of electronic tracking tool and training of staff.

Deloitte Consulting, LLP, New York, NYConsultant, 2007Business Analyst, 2005-2007Developed front-end process changesto improve free cash flow for severallarge hospital systems. Managed im-plementation of “Quick Win” strate-gies resulting in a one-time cashacceleration of $2.8M. Led regionalimplementation of Revenue Protecttool at 3 facilities.

Michelle Gee-eun Leemichelle.lee.wg12@wharton.upenn.eduHarvard University, Cambridge, MAA.B., Magna Cum Laude, Sociology, 2001

To improve the efficiency and effective-ness of systems that support quality andaccessible healthcare provision.

Kaiser Permanente, Oakland, CAPerformance Excellence Intern, Summer 2011Evaluated Kaiser’s capacity to absorbnew cohorts of resource-intensivemembers and identified additionalareas for investment. Developed an evidenced-based strategy for minimizing discomfort, anxiety anddisturbances to patients’ rest duringhospital inpatient stays.

IMS Consulting, New York, NY and London, UKEngagement Manager, 2005-2010Developed drug pricing, reimburse-ment, and market access strategiesacross more than 30 therapeutic areasand 35 countries. Project-managedover 20 projects, representing $7-8Min revenues. Supervised several of thedivision’s first collaborations with affiliates in emerging markets in Asia,South America, and Africa. OversawIMS’s first engagement in the globalhealth sector, resulting in the division’sfirst white paper publication and theestablishment of the IMS GlobalHealth Initiative.

Monitor Group, Cambridge, MAConsultant, 2001-2003Oversaw the successful roll-out ofthree major components of a newpharmaceutical sales force model developed by Monitor, leading to unsolicited positive client feedback.Codified Monitor’s early perspectiveson venture philanthropy, nonprofitgrowth strategies, and the applicationof business frameworks in the nonprofit sector.

17

Roman Leiferroman.leifer.wg12@wharton.upenn.eduUniversity of Toronto, Toronto, ONB.A.S., High Distinction, Engineering Sciencewith concentration in Electrical Engineering,2007

An opportunity in principal investing.

CPPIB, Toronto, CanadaSummer Associate, Summer 2010Evaluated $100M-$1B Private Investments in Public Equity (PIPEs).Conducted in-depth due diligence on a potential $500M PIPE to enable atransformational international acquisi-tion in the engineering and construc-tion sector. Developed business planand evaluated deal economics for theMaple consortium’s bid to acquire the Toronto Stock Exchange (TSX) for $3.8B. Led CPPIB team’s emergingmarkets strategy for investments inAsia and Latin America.

Oliver Wyman, Toronto, CanadaConsultant, 2009-2010Analyst, 2007-2009Developed strategies for global firmsand conducted commercial diligenceto support transactions by both privateequity and strategic investors. Adviseda top pharmaceutical company on in-licensing and acquisitions and developed the intellectual capital intoa licensing platform. Managed the divestiture of the defense division of aleader in global logistics; worked withthe CFO to create a detailed financialmodel and coordinated the transac-tion process. Conducted diligence on a $300M energy services company with over 20 lines of business for a PE investor.

Oscar Linoscar.lin.wg12@wharton.upenn.eduUniversity of British Columbia, Vancouver, BCB.A., Biochemistry, 2005University of Toronto, Toronto, ONMaster of Biotechnology, 2007

Value investing across the healthcaresector in domestic and internationalpublic equities.

Earnest Partners, Atlanta, GAInvestment Intern, Summer 2011Analysed equities and served as member of investment committee.Recommended shorting Conmed(CNMD) against bullish surgery volumerebound; stock subsequently fell 16%on Q2 miss. Recommended long positions in global pharma and CPG on variant perception to Street views;correction expected in 12 months with30-40% returns. Researched BectonDickinson and identified upside inpharmaceutical systems and diagnos-tics segments, culminating in firm tak-ing sizable position. Researched namesin healthcare REIT, hospitals, and CPG.

Nycomed, Oakville, ONBusiness Development Manager, 2007-2010Originated and executed in-licensingdeals, closing 3 deals and conductingdue diligence on 10. Proposed and implemented oncology palliative carebusiness, estimated to generate $30Mannually. Sourced $250M cross-borderpartnership and co-led negotiation to final term sheet. Served as productmanager for allergy vaccine. ReceivedTop 1% rating in 2008 and 2009.

GlaxoSmithKline, Oakville, ONBusiness Operations Associate Intern, 2006-2007Implemented operational excellenceprogram, developed lean sigma project management office, and created balanced scorecard.

Gillian L. Marcottgillian.marcott.wg12@wharton.upenn.eduUniversity of Virginia, McIntire School of Commerce, Charlottesville, VAB.S., Beta Gamma Sigma, Commerce, with Finance and Marketing Concentrations, 2005

An opportunity to help identify anddrive long term value for healthcareservices businesses.

Medco Health Solutions, Franklin Lakes, NJSummer Associate, Summer 2011Analyzed purchase, prescription, andother demographic data to identifyhighest value group of customers forthe Medco Health Store. Led strategicgrowth initiative targeting diabeticpatients and formulated recommenda-tions on pricing, products and market-ing to increase revenue and profitmargins. Presented findings to groupleaders, leading to planned launch ofdiabetes CRM program.

Intellectual Ventures, Bellevue, WAAnalyst, 2009-2010Intellectual Ventures is a $5B fund thatcreates, acquires, and licenses technol-ogy inventions. Built 15+ acquisitionmodels to determine bid values for target portfolios. Created businessplans for key initiatives, forecastedgroup revenues and operating budgets, and defined group and client strategy. Researched 5 target industries and identified new areas for investment.

Jefferies & Company, New York, NYInvestment Banking Associate/Analyst,Healthcare Group, 2005-2008 Executed M&A and financing transac-tions for companies across the health-care industry. Performed complexvaluations, interacted directly withclients and managed due diligenceprocesses. Participated in Jefferies Finance rotation, focusing on creditanalysis, underwriting and syndicatingsenior loans.

18

Nadine S. McCarthynadine.mccarthy.wg12@wharton.upenn.eduUniversity of Cambridge, UKB.A., Natural Sciences, 2005

An opportunity to serve in commercialmanagement within the healthcare industry.

Novartis Pharmaceuticals, East Hanover, NJSummer Associate, New Products & Licensing, Summer 2011Led cross-functional team to evaluatethe optimal promotion strategy for a phase III pipeline product. Led a review of the U.S. COPD device strat-egy and evaluated demand for an up-graded device through physician andpayer research. Developed a workshopon the Patient Journey and presentedoutcomes to senior management; task-force set up to address identifiedareas of opportunity.

Monitor Group, London / ZurichEngagement Manager, 2005-2010Focused on corporate strategy, busi-ness development and marketing inthe healthcare industry. Four years ofmanagerial experience with between 2 to 4 direct reports on average. Led a team to develop the drug launchstrategy for a new biologic with a market potential of $2B. Defined aglobal portfolio strategy for femalecontraceptives (€2.6B annual sales).Advised board on commercial optionsfor a Phase II pharmaceutical product.Prepared proposals of new businessand participated in sales process. Received special recognition for developing new client methodologyand presented methodology to all senior partners at Europe-wide meeting.

Kirk R. McConnellkirk.mcconnell.wg12@wharton.upenn.eduStanford University, Palo Alto, CAB.A., Human Biology, 2007

An opportunity to improve healthcaredelivery through a role in strategy oroperations management.

Kaiser Permanente, Oakland, CACustomer Analytics and Business MarketingIntern, Summer 2011Identified and developed opportuni-ties to better use internal data re-sources to demonstrate value KaiserPermanente provides to customers.Strengthened process management ofcross-departmental analytical report-ing capabilities, elevating the qualityof deliverables while also enhancingoperational efficiency.

The Zitter Group, San Francisco, CAManager of Syndicated Research, 2008-2010Senior Analyst, 2008Analyst, 2007-2008 Authored 6 annual, multi-client research reports that provided pharmaceutical industry clients withcomprehensive understanding of U.S.healthcare system, largely focused onissues related to managed care. Lever-aged people and process managementskills to lead a cross-functional teamthrough content ideation, data collection, report development andsales/client management, resulting inon-time and highly marketable finaldeliverables that generated the high-est revenue levels in company’s history.Transformed research findings into actionable strategic recommendationsand worked with clients to define optimal managed care strategies and opportunities to improve perform-ance. Communicated findings throughin-person presentations, published articles, and speaking at professionalconferences.

Michael C. Mengmichael.meng.wg12@wharton.upenn.eduUniversity of Michigan Ross School of Business,Ann Arbor, MIB.B.A., High Distinction, Finance and Accounting, 2006

An opportunity in the alternative invest-ments industry focused on healthcare.

Moore Capital, New York, NYSummer intern, Summer 2011Analyze securities as it relates to themacroeconomic environment includinga variety of areas such as credit, rates,equities, commodities, and currencies.

Apax Partners, New York, NYAssociate, 2008-2010Identify, evaluate, and execute privateequity investments focusing on health-care for Apax Europe VII ($16B globalfund); monitor and improve portfoliocompanies. Key projects: potential$550M acquisition of a controllingstake in a leading lab diagnostics business in Brazil and Qualitest Phar-maceuticals (portfolio company), ageneric pharmaceutical manufacturerbased in the U.S.

Lazard Frères & Co., New York, NYAnalyst, 2006-2008Working as part of the investmentbanking team as the financial analystfocused on mergers and acquisitions inthe healthcare industry. Key projects:advising a large global pharmaceuticalcompany on the potential $6.3Bgroundbreaking acquisition of one ofthe largest Indian generic pharmaceu-tical companies and advising UCB on the $6.1B transformational cross-border acquisition of Schwarz Pharma.

19

Eleonora (Ella) Merjanova eleonora.merjanova.wg12@wharton.upenn.edu Duke University, Durham, NCB.S., Biology, B.A., Economics, 2006

Investing or operating role of impactwithin the health and wellness industry.

Physic Ventures, San Francisco, CASummer Associate, Summer 2011 Completed investment thesis and 30-page white paper on the future of healthy eating at home, focusing on digital media, social media, andconsumer internet innovation. Collaborated daily with the Directorsof U.S. Innovation for Unilever andPepsiCo, the two largest limited partners in Physic. .

Pro Mujer, New York, NYAssociate, 2009-2010Led international teams in review ofmicrofinance operations for 5 LatinAmerican countries; analysis resultedin strategic plan with goal to improveoperational efficiency by 35% in 3years.

Leerink Swann, New York, NYSenior Analyst, 2008-2009Identified and analyzed strategic alternatives for clients; built valuationmodel, developed 60-page marketingdocument, and managed relationshipbetween client and 12+ financial investors for leveraged buyout of$250M U.S. vaccines manufacturer.

Goldman Sachs, New York, NYFinancial Analyst, 2006-2008Analyzed domestic consumer trendsand behavior as part of principal investing team for $1B securitizeddebt fund; led efforts to structure $3Bin securitizations for domestic financialinstitutions.

Philip S. Mishkinphilip.mishkin.wg12@wharton.upenn.eduUniversity of Pennsylvania, Philadelphia, PAB.S.E., Summa Cum Laude, Chemical Engineering, 2006

An entrepreneurial opportunity withinthe biopharmaceutical sector, includingbusiness development, venture capital,or innovative start-ups.

Pfizer Inc., New York, NYBusiness Development Summer Associate,Summer 2011Conducted evaluations for 6 potential global transactions includingin-licenses, out-licenses and acquisi-tions spanning multiple stages of drugdevelopment and therapeutic areas.Led acquisition analysis of a privategenerics manufacturer and coordi-nated cross-functional team of R&D,Commercial, and Legal colleagues to frame and evaluate strategic and financial business case.

Deloitte Consulting, LLP, New York, NY and Philadelphia, PABusiness Analyst / Consultant, 2006-2010Led work-streams on multiple strategicengagements within the life sciencesindustry, executing projects across the value chain from R&D transforma-tional strategies to Sales & Marketingoptimization. Developed and co-authored Massachusetts BiotechnologyCouncil’s 2015 Strategic Report, whichdefined a strategic plan for Massachu-setts to maintain its global leadershipposition in biotechnology. Collabo-rated with the senior managementteam of a mid-tier pharmaceuticalcompany to transform the Sales &Marketing organization; recom-mended and developed 35 initiativesacross Sales, Marketing, and ManagedMarkets. Designed processes and supporting materials for a new R&D“collaboration model” at a global biopharmaceutical company.

Marc C. Montserrat marc.montserrat.wg12@wharton.upenn.eduETSEIB, Barcelona, SpainPolitecnico di Milano, Milan, ItalyFachhochshule Jena, Jena, GermanyB.S. and M.S., Industrial Engineering, 2004

20

An opportunity in an entrepreneurial organization to promote and deliver innovation in healthcare.

Genentech, South San Francisco, CAInteractive Marketing, Summer 2011 Led the creation of a framework to identify and quantify business opportunities in patient engagement, multicultural marketing and health literacy for pipeline and commercial-ized products. Recommendations tothe interactive marketing team and a senior VP-level committee received enthusiastically.

Almirall, Barcelona, SpainCorporate Project Manager, 2008-2010 Managed a global team of 40 mem-bers from 11 affiliates and partners in4 continents responsible for a portfolioof 43 products, growing sales from€9M in 2007 to €90M in 2010 repre-senting 66% of growth in company. Post-M&A integration responsibilities,working 25% of the time in Germany.

Siemens VDO, Rubi, SpainProject Manager, 2006-2008 Led international team of 19 members,managing 5 projects (€25M annualsales, 25% of plant turnover).Achieved safe launch of 30 products,including a project in 33% of standardlead-time, introduced 2 new technolo-gies, and created a new assembly lineconcept. Achieved business acquisitionof 3 projects (€90M revenue).

Altran, Barcelona, SpainConsultant, 2004-2006 Achieved €€3.4M savings in process optimization, actively participated in ramp-up of a new business unit including candidate interviews, projectprospection and offer preparation,and developed 3 new customers.

Haley A. Mosshaley.moss.wg12@wharton.upenn.eduWesleyan University, Middletown, CTB.A., Science in Society, 2007Perelman School of Medicine at the Universityof Pennsylvania, Philadelphia, PAM.D. Candidate, 2012

An opportunity to leverage my clinicaland business knowledge to improvehealthcare access, quality and delivery.

Center for Medicare and Medicaid Innovation, Baltimore, MDProject Fellow, Summer 2011-PresentFacilitate in the implementation of in-novative payment and delivery modelsto enhance quality and to address costdrivers of healthcare. Prioritize qualitymetrics for value-based payments toprimary care practices.

Leonard David Institute of Health Economics, Philadelphia, PAResearch Assistant, 2010-Present Identify ways to present medical information to patients to improve diabetes management and to increasepatients’ understanding of diseaseseverity.

Bridging the Gaps, Philadelphia, PAUniversity of Pennsylvania Coordinator, Summer 2010Oversaw meetings and provided resources to health and social servicegraduate student professionals. Organ-ized BTG Symposium where govern-ment officials, academic faculty andcommunity members participated inpublic health workshops.

University City Hospitality CoalitionClinic, Philadelphia, PAStudent Coordinator, 2007-2008Executed patient quality-initiatives ona limited budget. Directed outreach to student body to set clinic schedule.Developed patient educational and resource material about chronic dis-ease management and social services.

Colleen C. Murpheycolleen.murphey.wg12@wharton.upenn.eduThe University of Chicago, Chicago, IL B.A., Honors, Comparative Human Development, 2007

An opportunity to improve health care quality and access through the use of technology.

McKinsey and Company, Florham Park, NJSummer Associate, Business Technology Office, Summer 2011Assisted a government client with theimplementation of enterprise-wide ITtransformation to support healthcarereform. Conducted a diagnostic ofglobal IT project execution for a multi-national pharmaceutical client.

The Advisory Board Company, Washington, DCSenior Analyst, 2008-2010Analyst, 2007-2008Led research on operational challengesand new technologies for a client baseof over 400 hospital Chief InformationOfficers. Composed best-practice publications and presented research to hospital executives. Led internaltraining of over 100 employees on research methodology.

A Plus Illinois, Chicago, ILLead Research Assistant, 2006-2007Researched and reported on public education legislation for a consortiumof business and non-profit leaders focused on education funding reformin Illinois. Co-authored a successful$605,000 grant proposal to the Bill and Melinda Gates Foundation.

Wongdoody Advertising, Los Angeles, CAAccount Management Intern, Summer 2005Analyzed potential new clients andprepared materials for new businesspitches. Oversaw the production logistics for a deliverable distributed to over 50 clients nationwide.

Kalyan Pamarthykalyan.pamarthy.wg12@wharton.upenn.eduOsmania University, Hyderabad, IndiaB.E., University Medal, Computer Science & Engineering, 2005University of Minnesota, Twin CitiesM.S., Computer Science & Engineering, 2007

An opportunity focused on strategy andproduct marketing within the med-techor healthcare services industry.

Becton Dickinson Biosciences, San Jose, CAStrategic Marketing Summer Associate,Summer 2011Developed strategy to identify growthopportunities and increase marketpenetration in emerging markets forthe life science business. Performed extensive primary market research in India and recommended plans togrow the Indian business. Developed a framework to identify customerneeds and defined a metrics system to measure the incremental impact of innovative social computing toolsfor E-business.

Medtronic Cardiac Rhythm Management, Minneapolis, MNSoftware Engineer, 2007-2009Product Manager, 2010Led product planning and assisted in launch of cardiac remote patient management systems. Evaluated newproduct concepts and recommendedaction plan for pilot studies. Devel-oped and implemented processes toprioritize and manage customer needs.Led cross-functional teams to imple-ment high-priority customer needs for the Medtronic Paceart patient management system. Established andmanaged collaboration with the University of Minnesota to research innovative cardiac patient manage-ment techniques. Raised internal funding for proof-of-concept studiesto improve cardiac care using advanced analytics.

21

Jonathan Pearlsteinjonathan.pearlstein.wg12@wharton.upenn.eduStanford University, Palo Alto, CAB.A., Honors, Science, Technology, and Society, 2006

A strategic or business development opportunity in healthcare services and technology.

The TriZetto Group, Greenwood Village, COCorporate Strategy Intern, Summer 2011Defined consumerism strategy forpayer-focused health IT company. Evaluated market trends in insuranceexchanges, price transparency, and social media. Upward-managed execu-tive team, including Chief Strategy Officer, Chief Medical Officer, andFounder. Primary author of final deliv-erable presented to board of directors.

The Advisory Board Company, Washington, DCSenior Analyst, 2008-2010Analyst, 2007-2008Completed 7 best-practice researchstudies for hospital leaders, includingCIOs, Chief HR Officers, and ChiefNursing Officers. For each project, interviewed 80+ top executives atmajor health systems, analyzed find-ings, and developed final presentationdeliverable. Overall, more than 70% of clients rated studies “excellent,” the highest possible score. Example projects include: 1) mitigating nursingworkarounds related to clinical IT systems; 2) designing new-hire onboarding toolkit to improve staff retention.

National Opinion Research Center,Washington, DCResearch Assistant, 2006-2007Evaluated performance of $110M portfolio of health IT demonstrationprojects funded by Agency for Health-care Research and Quality (AHRQ). Employed SAS statistical software todiagnose key challenges and identifylongitudinal trends.

Laura E. Petersonlaura.peterson.wg12@wharton.upenn.eduDuke University, Durham, NCA.B., Public Policy, 2007

An opportunity in pharma/biotech strat-egy analysis or healthcare consulting.

Genentech, South San Francisco, CANew Product Commercialization (NPC) Commercial MBA Intern, Summer 2011Developed a consolidated roadmapand corresponding guidance document of U.S. commercial activitiesfor organizationally new therapeuticareas, taking into consideration existing U.S. and Global guidance documents and processes, ongoingRoche and Genentech initiatives, and industry best practices.

The Lewin Group, Falls Church, VAIndependent Consultant, 2010-2011Research Consultant, 2010Senior Research Analyst, 2008-2010Research Analyst, 2007-2008Led business development activities related to comparative effectivenessresearch and genomic data sharing resulting in over $5M in project workand the development of the LewinCenter for Comparative EffectivenessResearch. Facilitated government andregulatory affairs panels for majorpharmaceutical companies to developbusiness strategy. Developed a modelof the economic impact of a regula-tory pathway for follow-on biologicsfor the Assistant Secretary for Planningand Evaluation at DHHS that was ultimately adopted by the WhiteHouse Office of Healthcare Reform.Authored peer-reviewed journal articles, white papers and reports on health technology assessment, pharmaceutical market analysis, evidence-based medicine and comparative effectiveness research.

John Picassojohn.picasso.wg12@wharton.upenn.eduUniversity of Pennsylvania, Philadelphia, PAB.A., Cum Laude, Biology, 2006; B.S., Cum Laude, Economics, 2006

An opportunity within an entrepreneur-ial team to build and develop innovativehealthcare services ventures.

Fifth Street Finance, White Plains, NYSummer Associate, Summer 2011Created investment memorandums forover 10 middle-market, private equitydeals and closed 2 $100M+ transac-tions. Worked with CEO to build Busi-ness Development Center simulationto model fund raising process, invest-ment decisions, initial public offering,follow-on offerings, and capital markets leverage. Worked with ChiefInvestment Officer and Managing Director to develop firm’s health care investment strategy.

Accenture, New York, NYManager, Health Care Management Consulting Strategy, 2010Achieved fastest promotion to Manager from Business Analyst in history of Accenture Strategy practice.Developed integrated, multi-channelgo-to-market strategy for portfolio of sixteen pharmaceutical products.Managed implementation of go-to-market strategy across four Accentureworkstream teams, marketing vendors,client Brand Leads, and client’s managing project director; successful implementation led to 20-40% increase in sales effectiveness.

Consultant, 2008-2010Led 4 different project teams to develop strategic recommendations in Analytics, Marketing, Sales, andManaged Markets.

Business Analyst, 2007-2008

22

Ravi Raghavanravi.raghavan.wg12@wharton.upenn.eduMassachusetts Institute of Technology, MAB.S., Electrical Engineering and Computer Science, 2004B.S., Management Science, 2004University of Pennsylvania School of Engineering & Applied Science, Philadelphia, PAM.B. Candidate 2012

An opportunity in marketing or strategyfor an innovative healthcare company.

Medtronic, Mounds View, MNMarketing Intern, Summer 2011Developed a marketing launch planfor a next generation trans-catheter pulmonary heart valve. Validated the size and clarified the structure of pulmonary valve market. Recommend -ed and implemented an online implanter’s resource for product information. Planned and facilitatedbreakout sessions at the Pediatric Interventional Cardiologist Symposium to gather feedback on pre-clinical products.

Yaupon Therapeutics, Radnor, PACommercialization Consultant 2009-2010Developed a commercialization planfor a late stage cancer therapeuticdrug including strategies for managedcare, distribution, sales force allocation, and patient access.

SAP, Palo Alto, CAMarketing Manager 2007-2008Pre-Sales Consultant 2005-2007 Spent 14 months in India launching a customer references marketing program for South Asian customers.Developed over 50 business cases for selling SAP software to clients;business cases supported deals between $500,000 and $10M.

Dresdner Kleinwort, New York, NYAnalyst 2004-2005Created pitch books with profiles andvaluations of acquisition targets acrossEnergy, Industrial, and Healthcare industries.

Lindsay P. Randlindsay.rand.wg12@wharton.upenn.eduStanford University, Palo Alto, CAB.A., Departmental Honors, Psychology, Minor in Economics, 2007

A management position focusing onstrategy and operations for a healthcareprovider organization.

Kaiser Permanente, Oakland, CASenior Consulting Associate, Summer 2011Built new resource/staffing model tosupport budget allocation process forcase management teams supportingcomplex chronic conditions andMedicare/MediCal dual eligible populations. Conducted surveys andinterviews to gauge current stateworkflows, analyzed comprehensivepatient data and presented recom-mendations to regional leadership.Also designed playbook for NorthernCalifornia-wide roll out of hospital acquired pneumonia abatement initiative. Collaborated with teamleadership to identify best practices,assembled presentations for cross-region launches, and developed train-ing materials and templates to supportend-user adoption.

Accenture, Boston, MAAnalyst, Consultant, 2007-2010Assisted with design and implementa-tion of several Electronic MedicalRecord (EMR) systems. Interfaced directly with physicians and hospitaladministrators to define project parameters, tested system upgrades,trained end-users, and relayed hard-ware and software needs to externalvendors. Oversaw the pilot launch of leading Anesthesia EMR productand aided in strategic planning engagements for 2 major east coasthealth systems, focused on patient satisfaction and capital planning/-expansion.

James M. Rhodesjames.rhodes.wg12@wharton.upenn.eduHarvard College, Cambridge, MAB.A., Cum Laude, Economics, 2006

An opportunity in strategy or operationsin the healthcare provider space.

UMass Memorial Health Care, Worcester, MAAdministrative Resident, Summer 2011Partnered with physicians and adminis-trators at UMass Memorial Children’sMedical Center to analyze opportuni-ties to improve efficiency, clinical utilization and standardization in careon 3 inpatient units. Built patient flowdashboard for executives to identifybottlenecks in patient flow through-out the facility.

Deloitte Consulting LLP, Boston, MA and Los Angeles, CAConsultant, 2008-2010Business Analyst, 2006-2008Co-led 5 support services teams withhospital VPs and department Directors,creating mini-business plans to drive$25M in annual savings for a $2.1B, 9-hospital health system. Benchmarked21 shared services departments againstindustry best practices through inter-views and data analytics for a $462Mhealth system. Led the RespiratoryTherapy workstream for a $7.0B healthsystem’s clinical systems initiative,working with clinicians to define sys-tem content and layout to maximizepatient safety and improve outcomes.Performed market diligence on 5 potential new services for $7.7B hospital services outsourcing firm; designed high-level business models to drive market entry strategy andgrowth target.

23

Arunavo Royarunavo.roy.wg12@wharton.upenn.eduUniversity of Pennsylvania, Philadelphia, PAB.Sc. Economics (Wharton School) and B.A.Chemistry, Magna Cum Laude, 2004

An opportunity to leverage my back-ground and interest in the life sciencesindustry and in emerging markets.

Becton, Dickinson and Company,Franklin Lakes, NJ, U.S. and Delhi, IndiaInternational Strategic Marketing Intern, BD Medical, Summer 2011Researched and developed strategicframework and tactics for launch of a product targeted at the Indian outpatient segment. Spoke to manystakeholders and players while inIndia, both in healthcare and in organizations with operations in ruraland semi-urban areas. Findings andrecommendations presented to CEOand other senior executives. Recom-mendations are informing BD’s product launch planning.

Deloitte Consulting LLP, Strategy and Operations, Philadelphia, PAConsultant, 2007-2010Analyst, 2005-2007Worked with a variety of clients in thebiopharmaceutical industry, ranging insize from industry leaders to a biotechstartup. Project experiences coveredthe full range of functional groups, including sales and market, researchand development, manufacturing, realestate and support functions such as IT.Similarly, gained exposure to a widevariety of project types, from productlaunch planning to post-merger inte-gration to supply chain management.Ranked in top 10% of analysts for firsttwo years and was subsequently promoted to Consultant. Achieved direct supervisory responsibility for internal junior staff during time as a Consultant.

Frances E. Schendlefrances.schendle.wg12@wharton.upenn.eduPrinceton University, Princeton, NJA.B., Cum Laude, Woodrow Wilson School of Public and International Affairs, 2006

An opportunity to serve in a strategic or management role within healthcareservices or delivery.

Bain and Company, Boston, MAConsultant, 2009-2010Senior Associate Consultant, 2008-2009Associate Consultant, 2006-2008Worked with teams to tackle clients’strategic and operational issues, whilebuilding senior client relationships anddeveloping junior talent. Project expe-rience includes: developed a model fora payment reform pilot program for astate-level healthcare coalition; identi-fied opportunities to outsource a phar-macy service provider’s supply chain;prioritized strategic opportunities fora pharmaceutical company’s vaccinesand infectious diseases division; developed a 5-year growth strategy,budget, and fundraising plan for a violence prevention program of theBoys and Girls Clubs of Boston.

The Bridgespan Group, Boston, MAConsultant (Extern), 2009Used consulting skill set to work withnon-profit organizations and founda-tions. Project experience includes: developed a strategy for the RobertWood Johnson Foundation’s Vulnera-ble Populations Team; prepared 2mental health services organizationsfor a merger; conducted “scenarioplanning” for a mental health servicesorganization to understand the possi-ble impact of political and economicfactors and to identify strategic priori-ties for each scenario.

Ankit Shahankit.shah.wg12@wharton.upenn.eduMarquette University, Milwaukee, WIB.S., Cum Laude, Biomedical Engineering, 2003M.S., Biomedical Engineering, 2005

An opportunity to leverage my technical and commercial skills with an entrepreneurial team in the medicaldevice industry.

SV Life Sciences, Boston, MASummer Associate, Summer 2011Developed an investment thesis for interventional pain management. Interviewed physicians and businessleaders to identify success criteria,sourced deals and recommended investment opportunities. Partneredwith CEO and founders of a vascularportfolio company to analyze exit scenarios and outline a strategic plan to engage potential acquirers. Observed board meeting and partici-pated in diligence process.

Medtronic, Santa Rosa, CAPipeline Marketing Manager, Endovascular Innovations, 2008-2010Led strategic initiatives for next generation aortic vascular devices by conducting opportunity assessments of emerging technologies, and evalu-ating market trends and competitivepositioning to drive future businessgrowth.

Scientist, CardioVascular, 2006-2008Built and led 7 person team to developnovel animal model to simulatehuman atherosclerotic disease. Filedpatent applications for bioabsorbablestent technologies to strengthen company’s product pipeline.

U.S. Food and Drug Administration, Laurel, MDMedical Device Fellow, 2005-2006Designed blood vessel perfusion system to study pharmacokinetics andpharmacodynamics of locally deliveredtherapeutics. Assisted in preclinicalstudies to evaluate cardiovascular devices.

24

Monika S. Shahmonika.shah.wg12@wharton.upenn.eduUniversity of California, Berkeley Berkeley, CAB.A., High Honors, Applied Mathematics, 2005

An opportunity with an early stagehealthcare venture.

Warby Parker, New York, NYMBA Intern, Summer 2011Operations and strategy for high-growth, early stage eyewear company.Evaluated and implemented improve-ments in customer service systems,metrics, and human resources strategy.Evaluated business development opportunities for market potential and strategic fit and developed pilotand execution plan for most attractiveopportunity.

Acumen Fund, Hyderabad, IndiaPortfolio Associate, November 2008-July 2010Led due diligence and deal sourcing to grow a $15M healthcare portfolioserving low-income, mass markets in India. Managed 3 hospital investments in maternity care, chronicdisease management, and eye care.Evaluated 100+ investments in health-care infrastructure and technologyacross India.

Bain & Company, San Francisco, CA and New Delhi, IndiaAssociate Consultant and Senior AssociateConsultant, September 2005-August 2008Worked on strategy, due diligence,and turnaround projects for clients intechnology, healthcare, and privateequity. Example cases include 1) consumer strategy for a Fortune 25 PC retailer 2) pipeline developmentstrategy for a mid-sized biotech firm 3) due diligence for 10+ targets for PE fund with $10B in capital undermanagement.

Ravi N. Shahravi.shah.wg12@wharton.upenn.eduPrinceton University, Princeton, NJA.B., Honors, Woodrow Wilson School of Public and International Affairs, 2006Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA M.D. Candidate, 2012

An opportunity to use my clinical andbusiness experience to improve thequality and delivery of healthcare.

McKinsey & Company, New York, NYSummer Associate, Summer 2011Created implementation plan for largehealth insurance company working to roll out patient-centered medicalhome model across the state. Developed comprehensive data plan(including clinical research trial design)for large pharmaceutical companylooking to change the landscape of diabetes treatment.

Mount Sinai Medical Center, New York, NYIntern, World Trade Center Medical Monitor-ing and Treatment Program, Summer 2008Revolutionized bill reconciliationprocess for $32M federally funded program serving 23,000+ workers involved in 9/11 cleanup by creating a user-friendly insurance system withinMicrosoft Excel to systematically reconcile bills against formularies.

Bridgewater Associates, Westport, CTInvestment Associate, 2006-2007Advised institutional investors such as pension funds and endowments on portfolio theory concepts includingseparation of alpha and beta investingand asset-liability management as partof strategic partnership that resultedin maintenance of almost 100% clientaccounts during period of flat invest-ment performance.

Jonathan R. Shannonjonathan.shannon.wg12@wharton.upenn.eduUniversity of Pennsylvania, Philadelphia, PAB.A., International Relations and Germanic Studies, 2007

An opportunity in the financial servicessector with a focus on healthcare.

UBS Investment Bank, New York, NYSummer Associate (Healthcare), Summer 2011Provided financial advice and serviceson several projects, across the health-care spectrum. Built financial modelsto analyze capital structures and impacts of M&A transactions. Assistedin buy-side process of a healthcareservice company to a group of finan-cial sponsors. Deals included Co-LeadUnderwriter for a $1.1B debt offeringfor WellPoint, Inc.

Booz & Company, New York, NYSenior Consultant (Healthcare), 2007-2010Delivered recommendations to clientsacross a variety of areas includingstrategic change, cost cutting initia-tives and portfolio development opportunities. Projects included: Advised the board of directors of alarge healthcare payor, on potentialnew lines of business and health IT initiatives which demonstrated increased annual revenue streams. Performed benchmarking study for a metropolitan healthcare provider,identifying cost savings in patient accounts via outsourcing and processconsolidation. Conducted health ITmarket opportunity analysis for amajor telecom company; identifying$46M annual revenue opportunity in health information exchange andhospital data storage.

25

Andrew D. Steinbergandrew.steinberg.wg12@wharton.upenn.eduDuke University, Durham, NCB.S.E., With Honors, Biomedical Engineeringand Economics, 2004Georgetown University, Washington, DCM.S., Biomedical Science Policy, 2008

An opportunity to finance and unlockvalue in healthcare innovation.

Goldman Sachs & Co., New York, NYAssociate, Healthcare IBD, Summer 2011Executed $1.9B take-private acquisi-tion of Immucor by TPG. DevelopedLBO and valuation models for diagnos-tic, medtech and healthcare servicefirms. Co-authored capital committeememo for a $500M take-private acquisition of a CRO.

Google, Mountain View, CASenior Associate, 2008-2010Led global finance team to develop a framework for internal investmentdecisions. Managed a $23B cross-prod-uct P&L and co-led global initiative toalign $8B of revenue by standardizingGoogle’s client management system.Provided analytics to senior executivesto manage Google’s sales organizationacross all geographies, channels andproducts.

Booz Allen & Hamilton, Mclean, VASenior Consultant, 2006-2008Designed post-merger IT enterprise infrastructure for commercial health-care payor resulting in a unified, scalable, nationwide platform. Devel-oped system requirements for an in-surance adjudication workflow system.

MPR Associates, Alexandria, VAEngineering Consulting, 2004-2005Developed medical device prototypesfor biomedical VCs, named on patentapplication for design of an ultra-sound periodontal tool, and led test-ing of an innovative electrophoresisdevice.

Kathryn F. Sullivankathryn.sullivan.wg12@wharton.upenn.eduDuke University, Durham, NCB.S.E., with Distinction, Biomedical Engineering, 2006

An opportunity to apply product marketing expertise to commercialize innovative medical technologies.

Medtronic, Minneapolis, MNMarketing Summer AssociateAtrial Fibrillation Solutions, Summer 2011Performed first worldwide review ofnewly launched product in cryoabla-tion system. Analyzed early sales toidentify trends in adoption and con-ducted quantifiable physician surveyto pinpoint opportunities. Deliveredwell-received recommendations forcross-functional leadership team:short-term marketing, training andclinical tactics to drive loyalty as wellas longer-term product developmentproposal for next generation catheter.

Omnicell, Mountain View, CAProduct Manager, 2007-2010Market Research Analyst, 2007-2008Established anesthesia automatedmedication dispensing product as keygrowth area and increased productdemonstrations to anesthesia depart-ments by 100% through ongoing salessupport. Designed and launched newhardware and software features tosurpass competition for the first timein product history. Selected to leadsoftware platform revamp includingportfolio-wide user interface refresh.Signed on prestigious hospital partners.

Capital One Financial Corp., McLean, VABusiness Analyst, 2006-2007Analyzed credit card customer behavior to develop and test rewardsprogram strategies to increase loyaltyand stimulate purchasing.

Vic Tandonvikas.tandon.wg12@wharton.upenn.eduRutgers University, New Brunswick, NJB.S., Public Health and Political Science, 2004Columbia University, New York, NYM.P.H., Health Policy and Management, 2006

An opportunity with an entrepreneurialorganization in the health IT or healthservices industry.

athenahealth, Watertown, MAMBA Intern, Product Strategy, Summer 2011Identified and assessed opportunitiesto expand the features and functional-ity of athenahealth’s patient communi-cations product. Developed businesscase for a $25M revenue opportunityover 5 years to expand product scope to include telemedicine services. Also worked to actively identify andevaluate new business opportunities,working cross-functionally with the Product Strategy, Business and Corporate Development teams.

CSC, West Orange, NJStaff Consultant, 2008-2010Associate Consultant, 2006-2008Conducted quantitative and qualita-tive analyses to identify and developnew business and service models toleverage digital health information incare delivery and life sciences researchand development, serving clients andinternal stakeholders. Examples in-clude: 1) opportunity assessment for$64B global healthcare company tolaunch a health management service,leading to multi-million dollar acquisi-tion; 2) work to develop and preparelaunch of CSC’s health data analyticsservices, including service definitionand creation of financial and staffingmodels; 3) market sizing and customersegmentation analysis in support ofdeveloping business plan for CSC’s con-sumer health self-management service.

26

Shin Ujiieshin.ujiie.wg12@wharton.upenn.eduThe University of Tokyo, Tokyo, JapanB.S., Agriculture, 2003M.S., Agricultural Life Science

An opportunity to combine my experience and expertise in life scienceand business arenas to create value inthe healthcare industry.

Eisai Co., Ltd., Tokyo, JapanAssociate, 2005-2010Conducted scientific and financial eval-uation of business development dealsincluding in-licensing and out-licensingdeals. Worked closely with researchersand business people to strategicallystreamline Eisai’s pipeline and establish Eisai’s mid- and long-termcorporate plans. Led due diligenceteams to acquire a $350M oncology focused biotechnology company, Morphotek Inc., and a $4B oncologyfocused specialized company, MGIPharma. Established and organizedR&D related committees such as GlobalOncology Committee and Eisai Scientific Advisory Board. Served asone of organizers of Eisai’s supremediscussion body, Global Policy andStrategy Council, and decision makingbody, the Executive Committee ofEisai. Established Eisai’s new operationin diagnostic arena with Sanko Jyun-yaku, now a wholely-owned subsidiaryof Eisai.

John A. Urquhartjohn.urquhart.wg12@wharton.upenn.eduBrown University, Providence, RIA.B., Business Economics and Public and Private Sector Organization, 2004

An opportunity to evaluate and invest inhealthcare companies and technologies.

Celgene Corporation, Summit, NJSummer Associate, Global Marketing Summer 2011Worked within cross functional teamsto identify global marketing best practices and implement value-add initiatives. Engaged outside expertiseto improve treatment duration andpatient adherence for oral oncologymedicine. Developed action plan for building disease specific mobile application physician tool. Assessedcommercial opportunity for indicationexpansion of existing product.

Cowen Healthcare Royalty Partners,Stamford, CTAssociate, 2008-2010Analyst, 2007First investment professional hired bynew private equity fund. Completed 9 transactions and invested over$300M in transactions of various struc-tures, including: royalty monetizations,synthetic royalty interests, structureddebt and equity investments. Responsible for building valuationmodels, structuring investments andconducting due diligence. Preparedfundraising marketing materials andcommunicated with existing andprospective limited partners.

SG Cowen Securities, Boston, MAInvestment Banking Analyst, 2004-2007Created financial models and performin-depth analysis of various transac-tions including buyside and sellsideM&A and equity financings for varietyof public and private technology/software companies.

Reed S. Van Gordenreed.van.gorden.wg12@wharton.upenn.eduNorthwestern University, Evanston, ILB.A., Economics and Biological Sciences, 2006CFA Charterholder, 2010

An opportunity to build successfulhealthcare companies through effectiveinvestment and management.

Actient Pharmaceuticals, Lake Forest, ILIntern, GTCR Portfolio CompanySummer 2011Evaluated the Urology/Gynecologylandscape for viable opportunities –ranked 16 disease states across 8 metrics and identified potential development and acquisition targetsin the top five disease states.

Genentech, San Francisco, CAIntern, Summer 2011Executed CEO initiated cost-benefitanalysis on sales meetings, clinical specialist days on-territory, and com-mercial travel expenses; conductedover 85 interviews throughout all levels of the sales division.

Abingworth Management, Waltham, MAAssociate, 2008-2010Provided Letter of Intent and led in-depth due diligence on 8 healthcaretargets; completed two transactions.Streamlined due diligence process by establishing formal metrics for review,improving competitiveness in managedprocesses. Individually responsible for33% of all GE deal flow; built deal network via cold-calling, networking and conferences. Built investment thesis around specific sub-sectors: HIT, Aesthetic Devices, Pathology and Molecular Laboratories.

J.P. Morgan, New York, NYAnalyst, 2006-2008Transactions: $37B LBO of Harrah’sCasinos; $7.3B LBO of CDW Corpora-tion; $7.1B LBO of Manor Care; $4.1BRevolving Credit Facility and $225Mrecapitalization for Patheon.

27

Elizabeth C. M. Violinelizabeth.violin.wg12@wharton.upenn.eduHarvard College, Cambridge, MAA.B., Psychology, 2007

An opportunity to create and executeasset commercialization strategy for a biopharmaceutical company.

Celgene, Summit, NJStrategic Marketing, Hematology, Summer 2011 Led project management of new product launch readiness efforts, collaborating with cross-functionalcore team represented by commercial,medical affairs, regulatory and manu-facturing senior leadership: Identifiedprocess flows, interdependencies, critical tasks, and risk mitigationstrategies. Led development of print and web communication strat-egy, managing third-party vendor engagement. Contributed to clinicaltrial and concept branding engage-ments, launch pricing research, andlong-term franchise planning strategydevelopment.

IMS Consulting, NY, NYConsultant, 2007-2009Delivered strategic consulting to biopharma and medical device companies. Focused on pricing and market access strategy. Managed client engagements focused on a spectrumof U.S. and global markets and thera-peutic areas. Sample projects includeleading in-depth analyses of U.S. managed care and potential value-based solutions for pharma-payer engagements in U.S. and China; managing across IMS practices to deliver a strategy for optimizing pharmacoeconomics research forpipeline oncology agents; and developing a U.S. launch pricing and contracting strategy for a diabetes agent.

Rom K. Wadehrarmit.wadehra.wg12@wharton.upenn.eduEmory University, Atlanta, GAB.B.A., Business and Economics, With Distinction, 2004University of Pennsylvania, Philadelphia, PAM.S.E., Systems Engineering, 2005

An opportunity to apply my experiencein consulting to address the strategicand marketing challenges of medtechand biopharma.

McKinsey & Company, Philadelphia, PASummer Associate, Summer 2011Investigated the landscape of thehealthcare supply chain to develop a$6B strategy to reduce the counterfeit-ing and diversion of prescription phar-maceuticals and biologics in the U.S. Contributed to a distributor’s 600-person sales force redesign by optimizing their retail pharmacy salesstrategy and developing a supportingorganizational structure that saved$3M annually.

InfoMC, Conshohocken, PABusiness Consultant, 2009-2010Co-led 50-person process reengineer-ing engagement to streamline ourclient’s behavioral health programsand execute a $70M acquisition.

Small Bone Innovations, Morrisville, PABusiness Analytics Supervisor, 2007-2009Built an intelligence department that managed the analysis of $35M in revenue across the firm’s 23 orthopedic product lines. Assisted amultidisciplinary team in launching the first fully mobile ankle implant in U.S.

Accenture, Philadelphia, PALife Sciences Analyst, 2005-2007Managed a team of clinicians and developers at a top biopharma firm to create a database system thatstreamlined clinical trials and reducedadministration time by 30%.

Shruti Wadgaonkarshruti.wadgaonkar.wg12@wharton.upenn.eduNorthwestern University, Evanston, ILB.A., Mathematical Methods in the Social Sciences and Economics, 2005

An opportunity to improve operationsand quality within a healthcare servicesor delivery provider.

Kaiser Permanente, Oakland, CASenior Consulting Associate, Summer 2011Created a prioritization process forconverting forms to an online formatto optimize patient convenience anddecrease costs. Designed performanceimprovement program to reduce surgi-cal site infections (SSI) by analyzingharm, evaluating cost/benefit of inter-ventions and developing a clinician operations playbook. Influenced clinical executives to approve the SSIreduction initiative which will reducedeaths and length of hospital stay. Engaged specialty physicians to defineand measure consult response times to improve hospital efficiency.

Mercer, Inc, Chicago, ILAssociate, 2008-2010Analyst, 2007-2008Provided executive and broad-basedcompensation consulting services tohealthcare and insurance organiza-tions. Designed hospital bonus andprofit-sharing programs by determin-ing eligibility, performance goals, andpayout formulas, resulting in pay mixalignment and substantial incentive toattain business goals. Built perform-ance management programs for companies with 4,000+ employees to drive individual/corporate performance.

Guy Carpenter and Company, Chicago, ILRisk Analyst, 2005-2007Calculated client risk tolerance and marketed clients’ businesses to reinsurance partners to generate affordable reinsurance solutions that minimized catastrophic damages.

28

Ofer Waksofer.waks.wg12@wharton.upenn.eduBen Gurion University, Beer Sheva, IsraelB.Pharm, Pharmacy, 2007

Dongyk Yoondongyk.yoon.wg12@wharton.upenn.eduYonsei University, Seoul, KoreaB.S., Electrical and Electronic Engineering, 2007

An opportunity in product managementor strategic planning in the medical device industry.

The Boston Consulting Group, Seoul, KoreaSummer Consultant, Summer 2011Assessed new healthcare business opportunity for the largest telecomcompany in Korea; identified 3 majorbusiness area and developed initial entrance strategy. Developed financialforecasting model for different acquisition alternatives and expansionscenarios. Performed 10 year revenueand EBITDA forecast for potential acquisitions of global healthcare companies.

Johnson & Johnson Medical, Seoul, KoreaSenior Product Specialist, 2010Product Specialist, 2007-2009Exceeded full-year individual sales target for 3 consecutive years throughdeployment of new sales and market-ing strategy; annual sales revenuegrew by 14% in 2007, by 30% in 2008and by 28% in 2009. Worked with AsiaPacific office to initiate quarterly livesurgery workshop, which helped sur-geons practice new surgical techniqueat Laboratory Animal Center and pro-vided customers unique value of hav-ing partnership with J&J. Led dealerteam to pursue sales opportunities insmall and medium-sized accountsbased on market segmentation analy-sis, and secured 50% revenue growthby focusing sales efforts on high potential hospitals. Selected as a first ever junior employee to receiveAsia Pacific top performer award for outstanding professional achievement.

Marketing Intern, Summer 2006Designed and developed intranet-based tool, which improved accessibil-ity of sales and marketing materialsand daily operational efficiency.

Marina V. Zeltsermarina.zeltser.wg12@wharton.upenn.eduColumbia University, New York, NYB.A., Biology, 2007Robert Wood Johnson Medical School, New Brunswick, NJM.D. Candidate, 2013

An opportunity to leverage my clinicaland business expertise to lead positivechange in healthcare delivery.

Accenture, New York, NYConsultant - Health Strategy, Summer 2011Supported consumerism strategy formajor regional health payer. Providedsubject matter expertise on providerhealth systems. Personally requestedby client for support on related projects. Developed internal knowledge on tax implications of health reform facing insurers.

Wharton Small Business Development CenterHealth Practice Leader, 2010-presentProvide strategic insight for CEOs ofhealth start-up companies. Presentedmarket entry strategy for start-upmedical device company. Conductedstrategic partnership analysis for pilotACO. Promoted from consultant levelto provide industry expertise, helpmanage client relationships, and support consultants.

National Healthcare Quality & SafetyLeadership Institute, Philadelphia, PAFounder and Co-Director, 2008-presentConceptualized first national trainingprogram on healthcare quality/safetyfor medical trainees; secured multi-year funding and collaboratedwith faculty to annually develop and teach the curriculum. Invited as student representative to nationalthought-leader meeting on medicaleducation reform on patient safety;co-author of report released by theNational Patient Safety Foundation.Featured in Modern Healthcare magazine.

29

An opportunity to leverage my pharma-ceutical expertise and my interest instrategic planning in a strategy or product development role in the healthcare industry.

Novartis Vaccines and Diagnostics, Cambridge, MAStrategic Marketing Intern, U.S. Marketing, Summer 2011Developed web consumer marketingstrategy and implementation path-ways following in-depth analysis of consumer behaviors and markettrends. Forecasted revenues and iden-tified key market trends for upcomingpipelined products, allowing improveddevelopment of annual marketingplan for new product launch. Led initial phase development and tacticsimplementation for physician focuseddisease awareness campaign, and im-proved data driven research by man-aging external agency involvement.

PPD, Tel-Aviv, IsraelClinical Research Associate, 2008-2010Led early-phase business developmentof new clinical studies by negotiatingphysician participation, increasing an-nual project volume by over 7.5%. En-hanced scope of QA department anddeveloped process improvements thatled to 40% operational cost savings. Created action plans ensuringincreased effectiveness of long termplanning in a variety of therapeuticareas through data analysis.

Maccabi Health Care Services, Tel-Aviv, IsraelPharmacist, Tel-Aviv Region, 2007-2008Developed marketing strategy for English speaking clientele by establish-ing in-house separate service units,leading to 20% increase in recurringbusiness. Increased sales by 72% by developing a display and checkoutplacement strategy.

THOMAS S. ROBERTSON, PH.D.Dean, The Wharton School

HOWARD KAUFOLD, PH.D.Vice Dean and Director,The Wharton Graduate Division

LAWTON R. BURNS, PH.D., M.B.A.Chair, Health Care Management Department, The Wharton School;Director, MBA Program in Health Care Management

JUNE M. KINNEY, M.A.Associate Director,MBA Program in Health Care Management

CHRISTINE ALESZCZYKAdministrative Coordinator,MBA Program in Health Care Management

JANICE SINGLETONAdministrative Coordinator,MBA Program in Health Care Management

Administration

30

SANDIP AGARWALASenior AssociateCeltic Pharmaceutical Management LPNew York, NY

AMEYA AGGEPrincipalApax PartnersLondon, UK

EUGENE ANProduct ManagerGenentechSouth San Francisco, CA

HEATHER ASPRASMarket Research Analyst– Marketing Management Associate ProgramMerck & Co.North Wales, PA

DAVID BAIADADivision Director, Practice LeaderBayada Nurses Moorestown, NJ

VIKRAM BAKHRU, MDDirector of Clinical ProcurementNew York Presbyterian HospitalNew York, NY

JOHN BARKETTPolicy AnalystOffice of Health Reform US Department of Health and Human Services Washington, DC

PETER R. BARNETT, DMDPresidentStar Ranch DentalPlano, TX

KEELY BECKDirector, Business & Commercial Analysis – OncologyGlaxoSmithKlineCollegeville, PA

ALI BEHBAHANIPrincipalNew Enterprise AssociatesWashington, DC

ERIC BELLSenior Director of Investment Strategy,Life SciencesInvention Development Fund, Intellectual VenturesSeattle, WA

W. RYAN BERGERManagerial ConsultantKaiser Permanente Santa Monica, CA

LINDA BERNIERSenior Vice President, Product Portfolio ManagementTriZettoBoston, MA

AJAY BIJOORVice PresidentMiller Buckfire & Co.New York, NY

KERUN BINDRASenior Manager, Corporate Development & StrategyMedimmune Vienna, VA

ADAM BIRNBAUMCorporate Development AssociateMedtronic Minneapolis, MN

DARREN BLACKPartnerSV Life SciencesBoston, MA

KATHERINE BOCKAssociate, Health Care Investment BankingLazard Freres & Co. LLCSan Francisco, CA

JAMES P. BODINEManaging DirectorBB&T Capital Markets– Healthcare Finance GroupPhiladelphia, PA

DANIEL BRANCO, MD, PHDFounderDMBrancoSão Paulo, SP – Brazil

SAM BRASCHDirectorKaiser Permanente VenturesOakland, CA

TOM L. BRODIndependent ConsultantNorth Shores ConsultingEvanston, IL

KARA FOWLER BROTEMARKLEMarket Planning ManagerGenentechSouth San Francisco, CA

LUCAS BUCHANANSenior Director of Marketing and Business DevelopmentSilk Road Medical, Inc.Sunnyvale, CA

SCOTT CANNIZZARO, PHDSenior DirectorJohnson & Johnson Radnor, PA

WILLIS CHANDLERSenior Vice President, Network DevelopmentUmass Memorial Health CareWorcester, MA

THIERRY CHAUCHÉDirectorNovartis PharmaceuticalsEast Hanover, NJ

GEORGE CHEN, MDVice PresidentJ&J Pharmaceutical RnDShanghai, China

GLADYS CHENProduct DirectorJohnson & Johnson CorporationRoyersford, PA

LU CHENProject LeaderThe Boston Consulting GroupNew York, NY

BRIAN G. CHOI, MDAssistant Professor of Medicine;Co-Director, Advanced Cardiac ImagingGeorge Washington UniversityWashington, DC

GLENN CHONGSenior DirectorRady Children's WaySan Diego, CA

EDUARDO A. CISNEROSCo-FoundersymbeoBloomfield, NJ

BRETT COHENRegional Vice President, OperationsKindred HealthcareAndover, MA

Health Care Program MentorsMentors are leaders and senior managers

in the healthcare field who have agreed

to provide career and professional

development advice and guidance to

Health Care Management Students.

2011

31

continued on next page

ROBB A. COHENChief Government Affairs OfficerXLHealthBaltimore, MD

REBECCA COOKEVice Dean for Administration and FinancePerelman School of Medicine at theUniversity of PennsylvaniaPhiladelphia, PA

DANIEL J. CURRAN, MDVice President, Corporate DevelopmentMillennium: The Takeda Oncology CompanyCambridge, MA

JAMES A. DATINExecutive Vice President and Managing Director,Life Sciences GroupSafeguard Scientifics, Inc.Wayne, PA

STEVEN J. DAVIDSON, MDChief Medical Informatics OfficerMaimonides Medical CenterBrooklyn, NY

ERIC DAVISSenior Director, InnovationAbbott Diabetes CareAlameda, CA

SETH DEMAINAnalystSAC Capital AdvisorsNew York, NY

CAYCE DENTONAssociateTPG BiotechSan Francisco, CA

LISA DUTTONDirector, Performance ImprovementVHA East Coast, Inc.Trevose, PA

Z. COLETTE EDWARDS, MDVice President and Senior Market Medical ExecutiveCIGNA HealthCareColumbia, MD

LISA EGBUONU-DAVIS, MD, MPHExecutive AdvisorBooz Allen HamiltonRockville, MD

RAMI ELGHANDOURAssociate, Venture InvestmentsJohnson & Johnson Development Corp.Fremont, CA

MYRIAM EXUMÉDirector, Apixaban Global MarketingBristol-Myers Squibb Co.Princeton, NJ

DANIEL FAGAPrincipalCenterview PartnersSan Francisco, CA

XIAOMING "MING" FANGAssociateMcKinsey Corporate FinanceSingapore / Asia

EVAN S. FIELDSTON, MD, MSHPAssistant Professor of PediatricsPerelman School of Medicine at the University of Pennsylvania Attending Physician,Division of General PediatricsThe Children’s Hospital of PhiladelphiaPhiladelphia, PA

THOMAS J. (T.J.) FILIP, DMDDentistGarber DentalBala Cynwyd, PA

CHRISTOPHER FIKRY, MDSenior Director, Commercial OperationsNovaritis Vaccines and DiagnosticsJersey City, NJ

BRIAN E. FLANIGANPrincipalDeloitte Consulting LLPChicago, IL

KATE J. FLYNNPresidentHealth Care Improvement FoundationPhiladelphia, PA

SHAUN FRANCISCEO and ChairmanMedcan Health Management Inc.Toronto, Ontario, Canada

BARRY R. FRANKELManaging DirectorFrankel Group LLCNew York, NY

SCOTT A. FREISHTATInvestment ProfessionalMiddle Market GroupH.I.G. CapitalNew York, NY

J.P. GALLAGHERPresident, Evanston HospitalEvanston Hospital, NorthShore UniversityHealthSystemEvanston, IL

MICHELE GALLUCCISenior Director, Business DevelopmentMedco Health Solutions IncFranklin Lakes, NJ

KATE GEORGENDirector, Commercial AssessmentOrtho-Clinical Diagnostics (a J&J Company)Raritan, NJ

MARIA A. GINGERICHIndependent ConsultantSeattle, WA

JEFFREY GOODWINGovernment Relations AssociateEmblemHealthNew York, NY

JASON P. GUPTAHealthcare Equity AnalystBennett Lawrence ManagementNew York, NY

TODD GURENProduct Development ManagerProvidence Health PlansPortland, OR

32

Health Care Program Mentorscontinued

CRISTINA GUTIERREZDirector of MarketingiRhythm Technologies, Inc.San Francisco, CA

PHILIP GUTRYPrincipalMPM CapitalSouth San Francisco, CA

ALISON K. HAGANSenior ManagerDeloitte ConsultingSan Francisco, CA

CAROLYN MAGILL HANSONChief Operating Officer,NJ Health Plan (Medicare / Medicaid)UnitedHealth GroupNewark, NJ

YUJIRO STEVE HATAVice President, Corporate Development & StrategyOnyx PharmaceuticalsSouth San Francisco, CA

BOSUN HAUPartnerMVM Life Science PartnersBoston, MA

LAUREN D. HAYVice PresidentDRI Capital Inc.Toronto, Ontario, Canada

JEFF HENSELAssociateBooz & CompanyFlorham Park, NJ

BRUCE W. HERDMAN, PHDChief of Medical OperationsPhiladelphia Prison SystemPhiladelphia, PA

SCOTT HIRSCHHealthcare Sector Analyst (Hedge Fund)Plural Investments LLCNew York, NY

BRUCE A. HOCHSTADT, MDPartnerMercerChicago, IL

SAMUEL H. HOLLIDAYAssociate, Healthcare Investment BankingJ.P. MorganNew York, NY

BRIAN HOLZERDirector, Strategy and Operations–Neulasta/NeupogenAmgen Inc.Thousand Oaks, CA

JARED P. HOPKINSFinance Senior Manager, Strategic and Enterprise AnalysisUniversity of Michigan Health SystemAnn Arbor, MI

MARK HURWICHPartnerThe London Perret Roche Group, LLCUpper Montclair, NJ

NOUHAD HUSSEINISenior Manager, Business DevelopmentGenentechSouth San Francisco, CA

MUDIT K. JAINPartnerSynergy Life Science PartnersPortola Valley, CA

VIVEK K. JAYARAMANVice President – Commercial OperationsTriVascular, Inc.Santa Rosa, CA

TRACY K. JOHNSONVice PresidentHealth Strategies and SolutionPhiladelphia, PA

VIKRAM JOSHIFounder and CEOProxim Diagnostics Corp.Sunnyvale, CA

LAN KANGGeneral Manager, Human Resources and Corporate Planningand Development DirectorFosum InternationalShanghai, China

VIKRAM KAPURManagerBain & Company Inc.New York, NY

DANIEL J. KARPDirector, Transactions, Worldwide Business DevelopmentPfizer, Inc.New York, NY

AMRITHA KASTURIRANGANAssistant Vice President/ Research AnalystFranklin Templeton InvestmentsChennai, Tamil Nadu, India

KARL M. KELLNERPartnerMcKinsey & CompanyNew York, NY

KEITH KERMAN, MDManaging DirectorPrimus Capital fundsCleveland, OH

RON C. KEROSenior Director Business DevelopmentVHA West Coast and Pacific NorthwestRenton, WA

DAVE KERWARDirector, Provider MarketsTriZettoBoston, MA

RUHI KHANVice President, Business DevelopmentAcorda TherapeuticsHawthorne, NY

LORENCE KIM, MDManaging DirectorGoldman SachsNew York, NY

JANHAVI KIRTANESenior Program Office, Beacon Communities ProgramHealth and Human Services/Office of National CoordinatorWashington, DC

LESLIE RHEE KOBYSenior ManagerPfizer Inc.New York, NY

MICHAEL KOBYManaging DirectorPalm VenturesGreenwich, CT

DAVID KONCIAKPrincipalFrankel GroupNew York, NY

MICHAEL KRAUTKRAMERDirector OperationsAvid RadiopharmaceuticalsPhiladelphia, PA

DAVID LAMACCHIABusiness Development ManagerCarestream Health, Inc.Rochester, NY

ROBERT J. LASKOWSKI, MDPresident and Chief Executive OfficerChristiana Care Health SystemWilmington, DE

FRANK D. LEESenior Director, Transplant Marketing and SalesGenentechSouth San Francisco, CA

LAWRENCE (LARRY) LEE, MDMedical Director, Analytics and Strategy;Primary Care Physician (Internal Medicine)HealthPartners, Inc.Minneapolis, MN

33

continued on next page

PATRICK LEEMarketing AssociateMedtronic NeuromodulationMinneapolis, MN

PABLO SANG M. LEE, MDSenior Manager, Global New Product PlanningImclone Systems Inc. (Eli Lilly and Company)New York, NY

RICHARD LEE, MDAssistant Professor,Department of UrologyWeill Medical College of Cornell UniversityNew York, NY

ELISABETH LEIDERMAN, MDVice PresidentCredit SuisseNew York, NY

JOHN M. LEWISRegional Vice PresidentathenahealthWatertown, MA

FRANK J. LEXA, MDVice Chairman, Department of RadiologyDrexel University College of MedicinePhiladelphia, PA

JOYCE LIAODirector, Corporate Developmentmoksha8 PharmaceuticalsWayne, PA

WALTER LIN, MDInvestment ManagerAscension Health VenturesSt. Louis, MO

LAUREN LISHERManager, Corporate Strategy and Business DevelopmentMcKesson CorporationSan Francisco, CA

JOAN R. MAGRUDERPresidentMissouri Baptist Medical CenterSt. Louis, MO

VIJAY MANTHRIPRAGADAVice PresidentGoldman SachsNew York, NY

JEFFREY D. MARRAZZOChief Executive OfficerMarrazzo Ventures, LLCBrooklyn, NY

ALISON MARXOperating Officer, Department of PediatricsThe Children's Hospital of PhiladelphiaPhiladelphia, PA

GREGG MCCONNELLGlobal New Business Manager – M&APfizerNew York, NY

ROBERT C. MCDONALD, MDPresidentAledo ConsultingIndianapolis, IN

JEAN M. MELLETTDirector of PlanningEastern Maine Healthcare SystemsBrewer, ME

GEOFF MEYERSONManaging Director and Co-FounderLocust Walk Partners, LLCCambridge, MA

RICK MODISenior Director, MarketingMedImmune / AstraZenecaPotomac, MD

MICHAEL MORROWInterim CFOChildren's Home Society & Family ServicesSt.Paul, MN

SERHIL (SERGE) MOSKALENKOAssociate Director, Market ResearchBMSJersey City, NJ

NABIL MOULINESenior DirectorMedco Health Solutions, Inc.Franklin Lakes, NJ

MARIA WHITMAN MUMMAssociate PrincipalZS AssociatesNew York, NY

PUSHKAR MURTHYInvestment AnalystClarivest Asset ManagementSan Diego, CA

HAREESH NAIRSr. Manager, Market Development(INTL Strategy & Business Development)Medtronic INTLSingapore

TY NELSONExecutive Vice PresidentHealth CarouselCincinnati, OH

WESLEY NURSSAssociateISI GroupNew York, NY

SARAH OLSONProduct ManagerMedtronic, Inc.Mounds View, MN

CARTER PAINESenior AssociateHealth Evolution PartnersSan Francisco, CA

JUSTIN PALLARIAssistant AdministratorIntermountain HealthcarePrimary Children’s Medical CenterSalt Lake City, UT

MONA C. PATELVice President, Neuromodulation MarketingBoston ScientificValencia, CA

CARY G. PFEFFER, MDPartnerThird Rock VenturesBoston, MA

34

Health Care Program Mentorscontinued

GARY M. PHILLIPS, MDPresident, North America Reckitt BenckiserRichmond, VA

MATTHEW PICKENSDirector of Strategic MarketingTranS1 Inc.Wilmington, NC

DAVE PINKERTPresident, National MarketThe TriZetto Group, Inc.Greenwood Village, CO

THOMAS QUEENANAssociate Vice President Treasury ServicesTemple University Health SystemPhiladelphia, PA

JEREMIAH RADANDTChief Financial OfficerPrimary Children's Medical CenterSalt Lake City, UT

RICHARD (RICHIE) RAKOWSKIFounder and PartnerIntersection, LLCWestport, CT

D. DEVI RAMANAN-STAUFFERHealth Outcomes, BioOncologyGenentech, Inc.South San Francisco, CA

DONNA BRADY RAZIANO, MDAssistant Chief Medical OfficerMercy Health System, Mercy LIFE Philadelphia, PA

MATT REBERVice PresidentCowen Healthcare Royalty PartnersStamford, CT

ERIC K. REDLINEBusiness Analysis and ConsultingPharmaMetricsPhiladelphia, PA

FARHAD RIAHI, MDHead, Healthcare Systems Novartis International AG Postfach Basel, Switzerland

MATT RIEKE, MDPartnerQuaker PartnersPhiladelphia, PA

PAMELA RODMANAdministratorColumbia UniversityNew York, NY

FRED RONNAUManager, Corporate Strategy & BusinessDevelopmentMcKesson San Francisco, CA

BEN ROOKSPrincipalST Advisors, LLCEvanston, IL

DAVID M. ROSHKIND, DMDPresidentGainesville Dental AssociatesGainesville, FL

DAVID SABLE, MDPortfolio Manager, Life SciencesSpecial Situations FundsNew York, NY

KEITH SAFIANPresident and CEOPhelps Memorial Hospital CenterSleepy Hollow, NY

ANIL SAGGIDirector, Corporate M&ANovartisBasel, Switzerland

VAIBHAV SARAIYAVice PresidentTwo Sigma Investments –Private Investment GroupNew York, NY

STEPHEN P. SCHRODELVice President, Hospital DevelopmentAu Bon PainBoston, MA

ALEX SCHUTH, MDAssociate Director, Business DevelopmentGenentech, Inc.South San Francisco, CA

MICHELLE SCHUTZProduct Manager, OncologyAbbott LabsChicago, IL

STACEY SELTZERAssociateAisling CapitalNew York, NY

SVEN SEYFFRETMarket Development ManagerMedtronic International Ltd.Singapore

NIRAJ SHAHVice President Global Sales – Cardiac SurgeryMAQUET CardiovascularSan Jose, CA

SHERI SHAPIROPractice Leader, Strategic Planning & Alignment and Accountable Care; Senior ConsultantThe Chartis GroupChicago, IL

ILANA SHATZSenior Manager, MarketingPfizer, Primary Care Business Unit, MarketingNew York, NY

DAVID A. SHEEHYPartnerAccenture Reston, VA

DANIEL A. SIMONEngagement ManagerMcKinsey & CompanyLondon, UK

THOMAS D. SIMSSenior DirectorGalloway ConsultingDunwoody, GA

ANNE SISSELVice President, Finance and Business DevelopmentVeracyteS San Francisco, CA

CHERYL SOLIT, MDManaging PartnerSolit Tessler and CompanyNew York, NY

MAUREEN A. SPIVACKManaging DirectorMorgan Keegan & Company, Inc.Investment BankingNew York, MA

JEREMY STACKAWITZPresident & CEOQuotient BiodiagnosticsNewtown, PA

35

continued on next page

36

JAMES STANFORDEngagement ManagerMcKinsey & CompanyPhiladelphia, PA

MEIR STEINDirector of Market DevelopmentSatellite HealthcareSan Jose, CA

JÉRÔME STEVENS, MDDirecteur général Direct MedicaBoulogne-Billancourt, France

ERIC M. STONEEntrepreneur/AdvisorMed Products, Services and ITSan Francisco, CA

MICHAEL STROUPVice PresidentUnited Surgical Partners (USPI)Nashville, TN

BETH SOMERS STUTZMANPrincipalSomers Stutzman & AssociatesLexington, MA

RUTH A. SUTERDirector, Market AccessBioMarin Pharmaceutical Inc.Novato, CA

FERNANDO TORRESManager – Corporate Strategy and Business DevelopmentMcKesson Technology ServicesAlpharetta, GA

ERIC TREPANIERAnalystO.S.S. Capital ManagementNew York, NY

BARBARA TROUPIN, MDSenior Director, Medical AffairsVIVUS, Inc.Mountain View, CA

RAY TSAI, MDMedical DirectorPhysicians For ChildrenDallas, TX

CINDY VANDERLINE-KOPPERVice PresidentPRTM Management ConsultantsChicago, IL

MICHAEL VIOLADirector, Capability DevelopmentAccolade, LLCPlymouth Meeting, PA

DAVID WALTONMarketing Director, New Product DevelopmentAnimas Corporation (a Johnson & Johnson Company)West Chester, PA

LYNN WANGManagerPfizerNew York, NY

RACHEL WASSERSTROMExecutive Administrator, OB/GYNBrigham and Women's HospitalBoston, MA

DONG WEIDirector, Program and Portfolio ManagementElan PharmaceuticalSouth San Francisco, CA

JASON WEIDMANVice President, Global Coronary & Peripheral Vascular MarketingMedtronicSan Rosa, CA

DAVID WENKARTVice PresidentBank of America Merrill LynchSydney NSW, Australia

TERRY WHITE, MDPhysicianHawaii Permanente Medical GroupHonolulu, Hawaii

CHRIS WILKERSONPresidentEquipSystems, LLCNew York, NY

MARKETA WILLS, MDDirector of Physician AffairsMemorial Hermann Hospital – Texas Medical Center CampusHouston, TX

AMY WILSONDirector, Campus Leadership Development Rotational ProgramsMedtronic, Inc.Minneapolis, MN

JOHN WINKELMANCEOWinkelman Associates, Inc.Irvine, CA

DANIEL YIPAssociate Director, Business OperationsAmicus TherapeuticsCranbury, NJ

ELLEN S. YOONGlobal Health Insurance Segment LeadIBM CorporationNew York, NY

SALEEM ZAFARSenior AssociateSevin Rosen FundsDallas, TX

WEI ZHANGPrincipalSafeguard Scientifics, Inc.Wayne, PA

THOMAS C. ZIPPBrand Insight Manager, SEROQUEL XRAstraZeneca PharmaceuticalsWilmington, DE

Health Care Program Mentorscontinued

37

The following organizations provided

internships for Health Care

Management Students in Summer, 2011.

5AM VENTURESWaltham, MA

A.T. KEARNEY Mexico City, Mexico

ABBOTT LABORATORIESSanta Ana, CAAbbott Park, IL

ACCENTURENew York, NY

ACCOLADEPlymouth Meeting, PA

ACTIENT PHARMACEUTICALSLake Forest, IL

AEGERION PHARMACEUTICALS, INC.Boston, MA

ATHENAHEALTHWatertown, MA

BANK OF AMERICA MERRILL LYNCHSan Francisco, CA

BECTON DICKINSON BIOSCIENCESSan Jose, CA

BECTON DICKINSON AND COMPANYFranklin Lakes, NJ Delhi, India

THE BOSTON CONSULTING GROUPBoston, MASeoul, Korea

CASTLIGHT HEALTHSan Francisco, CA

CELGENE CORPORATIONSummit, NJ

CENTER FOR MEDICARE AND MEDICAID INNOVATIONBaltimore, MD

CPPIBToronto, Ontario, Canada

EARNEST PARTNERSAtlanta, GA

EDG PARTNERSWashington, DC

EISAI CO., LTD.Tokyo, Japan

FIFTH STREET FINANCEWhite Plains, NY

GAMMA BASICSWayne, PA

GENENTECHSouth San Francisco, CA

GOLDMAN SACHS & CO.New York, NY

HOPELABRedwood City, CA

ION CAPITAL MANAGEMENTLondon, UK

J.P. MORGANNew York, NY

KAISER PERMANENTEOakland, CA

LLR PARTNERS INC.Philadelphia, PA

MCKESSONSan Francisco, CA

MCKINSEY & COMPANYPalo Alto, CAChicago, ILFlorham Park, NJNew York, NY Philadelphia, PADallas, TX

MEDCO HEALTH SOLUTIONSFranklin Lakes, NJ

MEDTRONICMinneapolis, MNMounds View, MN

MEDTRONIC CARDIOVASCULARMinneapolis, MN

MEDTRONIC – VENTOR TECHNOLOGIESNetanya, Israel

MOORE CAPITALNew York, NY

NOVARTIS PHARMACEUTICALS East Hanover, NJ

NOVARTIS VACCINES AND DIAGNOSTICSCambridge, MA

PFIZER INC.New York, NY

PHYSIC VENTURESSan Francisco, CA

ROCHE Nutley, NJ

SOLSTAS LAB PARTNERSGreensboro, NC

SV LIFE SCIENCESBoston, MA

TRINITY HEALTH Novi, MI

THE TRIZETTO GROUPGreenwood Village, CO

UBS INVESTMENT BANKNew York, NY

UMASS MEMORIAL HEALTH SYSTEMWorcester, MA

THE UNIVERSITY OF VIRGINIA MEDICAL CENTERCharlottesville, VA

VIVERE HEALTH, LLC Franklin, TN

WARBY PARKERNew York, NY

Internship Sponsors2011

The Program Faculty are drawn from

the Wharton School, the School of

Medicine, the School of Nursing, and

the School of Arts and Sciences at the

University of Pennsylvania and leading

health institutions in Philadelphia.

Additional support is provided by the

Fellows and Associates of the Leonard

Davis Institute of Health Economics.

EUGENIO ANESSI, PH.D.Professor, Public Management, Bocconi University Graduate School of Management, Milan, Italy; Lecturer and Senior Fellow, Health Care Management Department, The Wharton School

DAVID A. ASCH, M.D., M.B.A.Robert D. Eilers Professor of Health CareManagement and Economics; Professor of Medicine, Perelman School of Medicine at the University of Pennsylvania; Executive Director, Leonard Davis Institute of Health Economics

LAWTON R. BURNS, PH.D., M.B.A.Chair, Health Care Management Department, and Director, Health Care Management Program, The Wharton School, James Joo-Jin Kim Professor of Health Care Management, The Wharton School

PATRICIA M. DANZON, PH.D.Celia Z. Moh Professor of Health CareManagement and Insurance and RiskManagement, The Wharton School

GUY DAVID, PH.D.Assistant Professor, Health Care Management, The Wharton School

BENJAMIN DORANZ, PH.D., M.B.A.President and CEO, Integral Molecular,Inc.; Senior Fellow, Health Care Management, The Wharton School

MARK G. DUGGAN, PH.D.Professor, Business and Public Policy and Health Care Management, The Wharton School

ROBERT I. FIELD, J.D., PH.D., M.P.H.Professor of Law at the Earle Mack Schoolof Law and Professor of Health Manage-ment and Policy at the School of PublicHealth at Drexel University, Philadelphia;Lecturer, Health Care Management, The Wharton School

BRADLEY M. FLUEGELExecutive in Residence, Health Evolution Partners; Lecturer, Health Care Management, The Wharton School

THOMAS N. GILMORE, M.ARCH. Vice President, The Center for Applied Research Inc.;Senior Fellow, Health Care Management,The Wharton School

JOHN P. GLASER, PH.D.Chief Executive Officer,Health Systems Business Unit, Siemens;Lecturer, Health Care ManagementThe Wharton School

HENRY A. GLICK, PH.D.Professor of Medicine, Perelman School of Medicine at the University of Pennsylvania; Professor, Health Care Management, The Wharton School

SCOTT E. HARRINGTON, PH.D.Alan B. Miller Professor of Health CareManagement, and Insurance and RiskManagement, The Wharton School

JOHN C. HERSHEY, PH.D.Daniel H. Silberberg Professor of Operations & Information Management; Professor, Health Care Management, The Wharton School

NAOKI IKEGAMI, M.D.Professor, Keio University School of Medicine, Tokyo, Japan; Senior Fellow,Health Care Management, The Wharton School

JOHN KIMBERLY, PH.D.Henry Bower Professor of EntrepreneurialStudies; Professor of Management, Health Care Management, and Sociology, The Wharton School

JUNE M. KINNEY, M.A. Associate Director, Graduate Program in Health Care Management;Lecturer, Health Care Management, The Wharton School

WILLIAM L. KISSICK, M.D., D.P.H.Professor Emeritus

JONATHAN T. KOLSTAD, PH.D.Assistant Professor, Health Care Management, The Wharton School

GARY J. KURTZMAN, M.D.Vice President, Life Sciences, Safeguard Scientifics; Lecturer, Health Care Management, The Wharton School

JEFFREY P. LIBSON, J.D.Partner, Pepper Hamilton LLP; Lecturer, Health Care Management; The Wharton School

HARI MAHADEVAN, PH.D.Managing Partner, Rosetta Marketing;Lecturer and Senior Fellow, Health Care Management, The Wharton School

STEVEN A. NICHTBERGER, M.D.Lecturer and Senior Fellow, Health Care Management, The Wharton School

MARK V. PAULY, PH.D.John M. and Thomas L. Bendheim Professor; Professor, Health Care Management, Business and Public Policy, and Insurance and Risk Manage-ment, The Wharton School; Professor,Economics, College of Arts and Sciences;Faculty Co-Director, Roy and Diana Vagelos Program in Life Sciences & Management

WILLIAM P. PIERSKALLA, PH.D.Professor Emeritus

DANIEL POLSKY, PH.D.Professor of Medicine, Perelman School of Medicine at the University of Pennsylvania; Professor, Health Care Management, The Wharton School

DOUGLAS A. PRESENT, M.B.A.Chairman and CEO, Managed Health Care Associates, Inc.; Lecturer, Health Care Management, The Wharton School

ARNOLD J. ROSOFF, J.D.Professor, Legal Studies and Health Care Management, The Wharton School

STEPHEN M. SAMMUTVenture Partner, Burrill & Company; Lecturer and Senior Fellow, Health Care Management, Lecturer, Entrepreneurial Programs, The Wharton School

CYNTHIA SCALZI, M.N., PH.D.Professor Emeritus of Nursing and Health Care Management,The Wharton School

J. SANFORD SCHWARTZ, M.D.Leon Hess Professor in Internal Medicine, Perelman School of Medicine at the University of Pennsylvania; Professor, Health Care Management, The Wharton School

38

Faculty

39

JEFFREY H. SILBER, M.D., PH.D.Director, Center for Outcomes Research,The Children’s Hospital of Philadelphia;Professor of Pediatrics and Anesthesiology & Critical Care, Perelman School of Medicine at the University of Pennsylvania; Professor, Health Care Management,The Wharton School

JEFFREY A. SOLOMON, M.D.Associate Professor of Radiology, Perelman School of Medicine at the University of Pennsylvania; Associate Professor, Health Care Management, The Wharton School

AMANDA STARC, PH.D.Assistant Professor, Health Care Management, The Wharton School

ROBERT J. TOWN, PH.D.Associate Professor, Health Care Management The Wharton School

KEVIN G.M. VOLPP, M.D., PH.D.Professor of Medicine, Perelman School of Medicine at the University of Pennsylvania; Professor, Health Care Management, The Wharton School

JOHN J. WHITMAN, M.B.A.Executive Director, The TRECS Institute;President & CEO, RevolutionCare; Lecturer, Health Care Management, The Wharton School

SANKEY V. WILLIAMS, M.D.Sol Katz Professor of General Internal Medicine; Professor, Health Care Management, The Wharton School LAWTON R. BURNS, PH.D., M.B.A.

Director, MBA Program in Health Care Management, The Wharton School

JUNE KINNEYAssociate Director, MBA Program in Health Care ManagementThe Wharton School

The University of Pennsylvania values diversity and seeks talented students, faculty and staff from diversebackgrounds. The University of Pennsylvania does not discriminateon the basis of race, sex, sexual orientation, gender identity, religion,color, national or ethnic origin, age,disability, or status as a Vietnam EraVeteran or disabled veteran in the ad-ministration of educational policies,programs or activities; admissions policies; scholarship and loan awards;athletic, or other University adminis-tered programs or employment.

Questions or complaints regarding this policy should be directed to:Executive Director,Office of Affirmative Action and Equal Opportunity ProgramsSansom Place East3600 Chestnut Street, Suite 228Philadelphia, PA 19104-6106215.898.6993 (Voice)215.898.7803 (TDD)

©2004, The Trustees of the University of Pennsylvania. All rights reserved.

Photography of Students: Stuart WatsonBook Design: www.HollisterCreative.com

WhartonThe Wharton School University of Pennsylvania

MBA Program in Health Care Management3641 Locust WalkPhiladelphia, PA 19104-6218

215.898.6861fax 215.573.2157